Akslen er en sertifisert spesialist i kirurgisk patologi og leder forskningsgruppen Tumor Biology Research Group (etablert i 1995) ved Klinisk Institutt 1, Universitetet i Bergen. Siden 2013 har Akslen vært senterleder for Centre for Cancer Biomarkers CCBIO. Akslens gruppe og CCBIO arbeider med translasjonell kreftforskning med fokus på nye kreftmarkører og målrettet behandling og særlig mekanismer knyttet til hvordan kreftceller påvirkes av mikromiljøet i svulstene, og den betydning dette har for kreftspredning og dårlig prognose. Gruppen har prosjekter på ulike kreftformer, som brystkreft, ondartet melanom, prostatakreft og gynekologisk kreft. Gruppen kombinerer studier av humane tumorprøver med eksperimentelle celle- og dyremodeller. Det overordnede målet er å finne nye biomarkører som kan hjelpe oss til å forutse hvordan aggressive svulster vil utvikle seg og dermed bedre kunne skreddersy behandling.

Vitenskapelig artikkel

• Mirza, M.R.; Tandaric, Luka; Henriksen, J.R. et al. (2024). NSGO-OV-UMB1/ENGOT-OV30: A phase II study of durvalumab in combination with the anti-CD73 monoclonal antibody Oleclumab in patients with relapsed ovarian cancer. (ekstern lenke)
• Svanøe, Amalie Abrahamsen; Humlevik, Rasmus O. C.; Knutsvik, Gøril et al. (2024). Age-related phenotypes in breast cancer: A population-based study. (ekstern lenke)
• Røgenes, Hanna; Finne, Kenneth; Winge, Ingeborg et al. (2024). Development of 42 marker panel for in-depth study of cancer associated fibroblast niches in breast cancer using imaging mass cytometry. (ekstern lenke)
• Tornaas, Stian; Kleftogiannis, Dimitrios; Fromreide, Siren et al. (2024). Development of a high dimensional imaging mass cytometry panel to investigate spatial organization of tissue microenvironment in formalin-fixed archival clinical tissues. (ekstern lenke)
• Furriol Palmer, Jessica; Wik, Elisabeth; Aziz, Sura Mohammed et al. (2024). VEGFA gene variants are associated with breast cancer progression. (ekstern lenke)
• Klingen, Tor Audun; Chen, Ying; Aas, Hans et al. (2024). DDR2 expression in breast cancer is associated with blood vessel invasion, basal-like tumors, tumor associated macrophages, regulatory T cells, detection mode and prognosis. (ekstern lenke)
• Ingebriktsen, Lise Martine; Svanøe, Amalie Abrahamsen; Sæle, Anna Kristine Myrmel et al. (2024). Age-Related Clusters and Favorable Immune Phenotypes in Breast Cancer of the Young Patients. (ekstern lenke)
• Ohnstad, Hege Oma; Blix, Egil Støre; Akslen, Lars Andreas et al. (2024). Impact of Prosigna test on adjuvant treatment decision in lymph node-negative early breast cancer—a prospective national multicentre study (EMIT-1). (ekstern lenke)
• Lien, Hilde Eide; Berg, Hege Fredriksen; Halle, Mari Kyllesø et al. (2023). Single-cell profiling of low-stage endometrial cancers identifies low epithelial vimentin expression as a marker of recurrent disease. (ekstern lenke)
• Schuster, Cornelia; Akslen, Lars Andreas; Straume, Oddbjørn (2023). β2-adrenergic receptor expression in patients receiving bevacizumab therapy for metastatic melanoma. (ekstern lenke)
• Milosevic, Vladan; Edelmann, Reidunn Jetne; Winge, Ingeborg et al. (2023). Vessel size as a marker of survival in estrogen receptor positive breast cancer. (ekstern lenke)
• Chen, Ying; Klingen, Tor Audun; Aas, Hans et al. (2023). CD47 and CD68 expression in breast cancer is associated with tumor-infiltrating lymphocytes, blood vessel invasion, detection mode, and prognosis. (ekstern lenke)
• Thomsen, Liv Cecilie Vestrheim; Honore, Alfred; Reisæter, Lars Anders Rokne et al. (2023). A phase I prospective, non-randomized trial of autologous dendritic cell-based cryoimmunotherapy in patients with metastatic castration-resistant prostate cancer. (ekstern lenke)
• Kjølle, Silje; Finne, Kenneth; Birkeland, Even et al. (2023). Hypoxia induced responses are reflected in the stromal proteome of breast cancer. (ekstern lenke)
• Ehsani, Rezvan; Jonassen, Inge; Akslen, Lars Andreas et al. (2023). LOCATOR: feature extraction and spatial analysis of the cancer tissue microenvironment using mass cytometry imaging technologies. (ekstern lenke)
• Tsuruda, Kaitlyn ; Hoff, Solveig Kristin Roth; Akslen, Lars Andreas et al. (2023). Fatal and non-fatal breast cancers in women targeted by BreastScreen Norway: a cohort study . (ekstern lenke)
• Thomsen, Liv Cecilie Vestrheim; Kleinmanns, Katrin; Anandan, Shamundeeswari et al. (2023). Combining Mass Cytometry Data by CyTOFmerge Reveals Additional Cell Phenotypes in the Heterogeneous Ovarian Cancer Tumor Microenvironment: A Pilot Study. (ekstern lenke)
• Børretzen, Astrid; Reisæter, Lars Anders Rokne; Ringheim, Anders et al. (2023). Microvascular proliferation is associated with high tumour blood flow by mpMRI and disease progression in primary prostate cancer. (ekstern lenke)
• Lotsberg, Maria Lie; Røsland, Gro Vatne; Rayford, Austin James et al. (2022). Intrinsic Differences in Spatiotemporal Organization and Stromal Cell Interactions Between Isogenic Lung Cancer Cells of Epithelial and Mesenchymal Phenotypes Revealed by High-Dimensional Single-Cell Analysis of Heterotypic 3D Spheroid Models. (ekstern lenke)
• Sui, Lufei; Wang, Suming; Ganguly, Debolina et al. (2022). PRSS2 remodels the tumor microenvironment via repression of Tsp1 to stimulate tumor growth and progression. (ekstern lenke)
• Ingebriktsen, Lise Martine; Finne, Kenneth; Akslen, Lars Andreas et al. (2022). A novel age-related gene expression signature associates with proliferation and disease progression in breast cancer. (ekstern lenke)
• Thy, Jonas Evensen; Bhargava, Sameer; Larsen, Marthe et al. (2022). Early screening outcomes among non-immigrants and immigrants targeted by BreastScreen Norway, 2010–2019. (ekstern lenke)
• Ekanger, Camilla Tvedt; Zhou, Fan; Bohan, Dana et al. (2022). Human organotypic airway and lung organoid cells of bronchiolar and alveolar differentiation are permissive to infection by influenza and SARS-CoV-2 respiratory virus. (ekstern lenke)
• Wik, Elisabeth; Aziz, Sura Mohammed; Vethe, Heidrun et al. (2022). Neurogenesis and angiogenesis are associated features of aggressive breast cancer . (ekstern lenke)
• Hofvind, Solveig; Knutsvik, Gøril; Holen, Åsne Sørlien et al. (2021). Detection and significance of small and low proliferation breast cancer. (ekstern lenke)
• Strell, Carina; Stenmark Tullberg, Axel; Edelmann, Reidunn Jetne et al. (2021). Prognostic and predictive impact of stroma cells defined by PDGFRb expression in early breast cancer: results from the randomized SweBCG91RT trial. (ekstern lenke)
• Børretzen, Astrid; Gravdal, Karsten; Haukaas, Svein Andreas et al. (2021). The epithelial–mesenchymal transition regulators Twist, Slug, and Snail are associated with aggressive tumour features and poor outcome in prostate cancer patients. (ekstern lenke)
• Chen, Ying; Klingen, Tor Audun; Aas, Hans et al. (2021). Tumor-associated lymphocytes and macrophages are related to stromal elastosis and vascular invasion in breast cancer. (ekstern lenke)
• Krüger, Kristi; Silwal-Pandit, Laxmi; Wik, Elisabeth et al. (2021). Baseline microvessel density predicts response to neoadjuvant bevacizumab treatment of locally advanced breast cancer. (ekstern lenke)
• Hofvind, Solveig; Moshina, Nataliia; Holen, åsne Sørlien et al. (2021). Interval and Subsequent Round Breast Cancer in a Randomized Controlled Trial Comparing Digital Breast Tomosynthesis and Digital Mammography Screening. (ekstern lenke)
• Klingen, Tor Audun; Chen, Ying; Aas, Hans et al. (2021). Fibulin-2 expression associates with vascular invasion and patient survival in breast cancer. (ekstern lenke)
• Moshina, Nataliia; Falk, Ragnhild Sørum; Botteri, Edoardo et al. (2021). Quality of life among women with symptomatic, screen-detected, and interval breast cancer, and for women without breast cancer: a retrospective cross-sectional study from Norway. (ekstern lenke)
• Strell, Carina; Folkvaljon, Dick; Holmberg, Erik et al. (2021). High PDGFRB expression predicts resistance to radiotherapy in DCIS within the SweDCIS randomized trial. (ekstern lenke)
• Engelsen, Agnete ; Wnuk-Lipinska, Katarzyna; Bougnaud, Sébastien et al. (2020). AXL is a driver of stemness in normal mammary gland and breast cancer. (ekstern lenke)
• Seo, Mikyung Kelly; Straume, Oddbjørn; Akslen, Lars A. et al. (2020). HSP27 Expression as a Novel Predictive Biomarker for Bevacizumab: is it Cost Effective?. (ekstern lenke)
• Landi, Maria Teresa; Bishop, David Timothy; MacGregor, Stuart et al. (2020). Genome-Wide association meta-analyses combining multiple risk phenotypes provide insights into the genetic architecture of cutaneous melanoma susceptibility . (ekstern lenke)
• Lofterød, Trygve; Frydenberg, Hanne; Flote, Vidar Gordon et al. (2020). Exploring the effects of lifestyle on breast cancer risk, age at diagnosis, and survival: the EBBA-Life study. (ekstern lenke)
• Kleinmanns, Katrin; Bischof, Katharina; Anandan, Shamundeeswari et al. (2020). CD24-targeted fluorescence imaging in patient-derived xenograft models of high-grade serous ovarian carcinoma. (ekstern lenke)
• Reisæter, Lars Anders Rokne; Halvorsen, Ole Johan; Beisland, Christian et al. (2020). Assessing extraprostatic extension by mpMRI of the prostate: Mehralivand’s EPE grade or EPE Likert score?. (ekstern lenke)
• Lotsberg, Maria Lie; Wnuk-Lipinska, Katarzyna; Terry, Stéphane et al. (2020). AXL Targeting Abrogates Autophagic Flux and Induces Immunogenic Cell Death in Drug-Resistant Cancer Cells. (ekstern lenke)
• Askeland, Cecilie; Wik, Elisabeth; Finne, Kenneth et al. (2020). Stathmin expression associates with vascular and immune responses in aggressive breast cancer subgroups. (ekstern lenke)
• Sui, Lufei; Wang, Suming; Rodriguez, Roberto et al. (2020). Notch1 regulates breast cancer stem cell function via a non-canonical cleavage-independent pathway . (ekstern lenke)
• Schuster, Cornelia; Akslen, Lars A.; Stokowy, Tomasz et al. (2019). Predictive value of angiogenic proteins in patients with metastatic melanoma treated with bevacizumab monotherapy. (ekstern lenke)
• Hugdahl, Emilia Signe; Bachmann, Ingeborg M.; Schuster, Cornelia et al. (2019). Prognostic value of uPAR expression and angiogenesis in primary and metastatic melanoma. (ekstern lenke)
• Bhargava, Sameer; Akslen, Lars A.; Bukholm, Ida Rashida Khan et al. (2019). Performance measures among non-immigrants and immigrants attending BreastScreen Norway: a population-based screening programme. (ekstern lenke)
• Opsahl, Else Marie; Akslen, Lars A.; Schlichting, Ellen et al. (2019). The Role of Calcitonin in Predicting the Extent of Surgery in Medullary Thyroid Carcinoma: A Nationwide Population-Based Study in Norway. (ekstern lenke)
• Børretzen, Astrid; Gravdal, Karsten; Haukaas, Svein Andreas et al. (2019). FOXC2 expression and epithelial–mesenchymal phenotypes are associated with castration resistance, metastasis and survival in prostate cancer. (ekstern lenke)
• Lende, Tone Hoel; Austdal, Marie; Varhaugvik, Anne Elin et al. (2019). Influence of pre-operative oral carbohydrate loading vs. standard fasting on tumor proliferation and clinical outcome in breast cancer patients - a randomized trial. (ekstern lenke)
• Lende, Tone Hoel; Austdal, Marie; Bathen, Tone Frost et al. (2019). Metabolic consequences of perioperative oral carbohydrates in breast cancer patients - an explorative study. (ekstern lenke)
• Hofvind, Solveig; Holen, åsne Sørlien; Aase, Hildegunn Siv et al. (2019). Two-view digital breast tomosynthesis versus digital mammography in a population-based breast cancer screening programme (To-Be): a randomised, controlled trial. (ekstern lenke)
• Tsuruda, Kaitlyn; Hofvind, Solveig; Akslen, Lars A. et al. (2019). Terminal digit preference: a source of measurement error in breast cancer diameter reporting. (ekstern lenke)
• Smeland, Hilde Ytre-Hauge; Askeland, Cecilie; Wik, Elisabeth et al. (2019). Integrin α11β1 is expressed in breast cancer stroma and associates with aggressive tumor phenotypes.. (ekstern lenke)
• Tsuruda, Kaitlyn ; Bhargava, Sameer; Akslen, Lars A. et al. (2019). Forløpstider i Mammografi-programmet før og etter innføring av pakkeforløp for brystkreft . (ekstern lenke)
• Lofterød, Trygve; Mortensen, Elin Synnøve; Nalwoga, Hawa et al. (2018). Impact of pre-diagnostic triglycerides and HDL-cholesterol on breast cancer recurrence and survival by breast cancer subtypes. (ekstern lenke)
• Robsahm, Trude Eid; Helsing, Per; Nilssen, Yngvar et al. (2018). High mortality due to cutaneous melanoma in norway: A study of prognostic factors in a nationwide cancer registry. (ekstern lenke)
• Moshina, Nataliia; Sebuødegård, Sofie; Lee, Christoph I. et al. (2018). Automated volumetric analysis of mammographic density in a screening setting: Worse outcomes for women with dense breasts. (ekstern lenke)
• Valla, Marit; Mjønes, Patricia; Engstrøm, Monica J et al. (2018). Characterization of FGD5 expression in primary breast cancers and lymph node metastases. (ekstern lenke)
• Fonnes, Tina; Trovik, Jone; Edqvist, Per-Henrik D. et al. (2018). Asparaginase-like protein 1 expression in curettage independently predicts lymph node metastasis in endometrial carcinoma: a multicentre study. (ekstern lenke)
• Opsahl, Else Marie; Akslen, Lars A.; Schlichting, Ellen et al. (2018). Trends in diagnostics, surgical treatment, and prognostic factors for outcomes in medullary thyroid carcinoma in Norway: A nationwide population-based study. (ekstern lenke)
• Jokela, Tiina; Svendsen, Agnete; Rybicka, Agata et al. (2018). Microenvironment-Induced Non-sporadic Expression of the AXL and cKIT Receptors Are Related to Epithelial Plasticity and Drug Resistance. (ekstern lenke)
• Pilskog, Martin; Bostad, Leif; Edelmann, Reidunn Jetne et al. (2018). Tumour cell expression of interleukin 6 receptor a is associated with response rates in patients treated with sunitinib for metastatic clear cell renal cell carcinoma. (ekstern lenke)
• Dimitrakopoulou, Konstantina; Wik, Elisabeth; Akslen, Lars A. et al. (2018). Deblender: A semi-/unsupervised multi-operational computational method for complete deconvolution of expression data from heterogeneous samples. (ekstern lenke)
• Ramnefjell, Maria; Aamelfot, Christina; Helgeland, Lars et al. (2017). Low expression of SerpinB2 is associated with reduced survival in lung adenocarcinomas. (ekstern lenke)
• Hugdahl, Emilia Signe; Kalvenes, May Britt; Mannelqvist, Monica et al. (2017). Prognostic impact and concordance of TERT promoter mutation and protein expression in matched primary and secondary cutaneous melanoma. (ekstern lenke)
• Aziz, Sura Mohammed; Wik, Elisabeth; Knutsvik, Gøril et al. (2017). Extra-nodal extension is a significant prognostic factor in lymph node positive breast cancer. (ekstern lenke)
• Ramnefjell, Maria; Aamelfot, Christina; Helgeland, Lars et al. (2017). Vascular invasion is an adverse prognostic factor in resected non?small-cell lung cancer. (ekstern lenke)
• Klingen, Tor Audun; Chen, Ying; Aas, Hans et al. (2017). Tumor-associated macrophages are strongly related to vascular invasion, non-luminal subtypes, and interval breast cancer. (ekstern lenke)
• Berg, Anna; Gulati, Ankush; Ytre-Hauge, Sigmund et al. (2017). Preoperative imaging markers and PDZ-binding kinase tissue expression predict low-risk disease in endometrial hyperplasias and low grade cancers. (ekstern lenke)
• Tangen, Ingvild Løberg; Venereis, Jennifer Taylor; Halle, Mari Kyllesø et al. (2017). Expression of glucocorticoid receptor is associated with aggressive primary endometrial cancer and increases from primary to metastatic lesions. (ekstern lenke)
• Fonnes, Tina; Berg, Hege Fredriksen; Onyango, Therese Bredholt et al. (2017). Asparaginase-like protein 1 is an independent prognostic marker in primary endometrial cancer, and is frequently lost in metastatic lesions. (ekstern lenke)
• Valla, Marit; Engstrøm, Monica J; Ytterhus, Borgny et al. (2017). FGD5 amplification in breast cancer patients is associated with tumor proliferation and a poorer prognosis. (ekstern lenke)
• Kraby, Maria Ryssdal; Opdahl, Signe; Akslen, Lars A. et al. (2017). Quantifying tumour vascularity in non-luminal breast cancers. (ekstern lenke)
• Fang, Jun; Jia, Jinping; Makowski, Matthew et al. (2017). Functional characterization of a multi-cancer risk locus on chr5p15.33 reveals regulation of TERT by ZNF148. (ekstern lenke)
• Ramnefjell, Maria; Aamelfot, Christina; Aziz, Sura Mohammed et al. (2017). Microvascular proliferation is associated with aggressive tumour features and reduced survival in lung adenocarcinoma.. (ekstern lenke)
• Reisæter, Lars Anders Rokne; Futterer, Jürgen J.; Losnegård, Are et al. (2017). Optimising preoperative risk stratification tools for prostate cancer using mpMRI. (ekstern lenke)
• Krüger, Kristi; Wik, Elisabeth; Knutsvik, Gøril et al. (2017). Expression of Nestin associates with BRCA1 mutations, a basal-like phenotype and aggressive breast cancer. (ekstern lenke)
• Pilskog, Martin; Beisland, Christian; Akslen, Lars A. et al. (2017). Predictive value of C-reactive protein in patients treated with sunitinib for metastatic clear cell renal cell carcinoma. (ekstern lenke)
• Helsing, Per; Robsahm, Trude Eid; Vos, Linda et al. (2016). Cutaneous head and neck melanoma (CHNM): A population-based study of the prognostic impact of tumor location.. (ekstern lenke)
• Nygård, Yngve; Haukaas, Svein Andreas; Halvorsen, Ole Johan et al. (2016). A positive Real-Time Elastography (RTE) combined with a Prostate Cancer Gene 3 (PCA3) score above 35 convey a high probability of intermediate- or high-risk prostate cancer in patient admitted for primary biopsy. (ekstern lenke)
• Knutsvik, Gøril; Collett, Karin; Arnes, Jarle et al. (2016). QSOX1 expression is associated with aggressive tumor features and reduced survival in breast carcinomas. (ekstern lenke)
• Klingen, Tor Audun; Chen, Ying; Stefansson, Ingunn et al. (2016). Tumour cell invasion into blood vessels is significantly related to breast cancer subtypes and decreased survival. (ekstern lenke)
• Frydenberg, Hanne; Thune, Inger; Lofterød, Trygve et al. (2016). Pre-diagnostic high-sensitive C-reactive protein and breast cancer risk, recurrence, and survival. (ekstern lenke)
• Schuster, Cornelia; Akslen, Lars A.; Straume, Oddbjørn (2016). Expression of Heat Shock Protein 27 in melanoma metastases is associated with overall response to bevacizumab monotherapy: Analyses of predictive markers in a clinical phase II study. (ekstern lenke)
• Hugdahl, Emilia Signe; Kalvenes, May Britt; Puntervoll, Hanne Eknes et al. (2016). BRAF-V600E expression in primary nodular melanoma is associated with aggressive tumour features and reduced survival. (ekstern lenke)
• Wang, Suming; Blois, Anna; El Rayes, Tina et al. (2016). Development of a prosaposin-derived therapeutic cyclic peptide that targets ovarian cancer via the tumor microenvironment. (ekstern lenke)
• Nalwoga, Hawa; Ahmed, Lavina; Arnes, Jarle et al. (2016). Strong expression of hypoxia-inducible factor-1α (HIF-1α) is associated with Axl expression and features of aggressive tumors in African breast cancer. (ekstern lenke)
• Hofvind, Solveig; Holen, åsne Sørlien; Roman, Martha et al. (2016). Mode of detection: an independent prognostic factor for women with breast cancer.. (ekstern lenke)
• Aziz, Sura Mohammed; Wik, Elisabeth; Knutsvik, Gøril et al. (2016). Evaluation of Tumor Cell Proliferation by Ki-67 Expression and Mitotic Count in Lymph Node Metastases from Breast Cancer. (ekstern lenke)
• Opsahl, Else Marie; Brauckhoff, Michael; Schlichting, Ellen et al. (2016). A nationwide study of multiple endocrine neoplasia type 2A in Norway: predictive and prognostic factors for the clinical course of medullary thyroid carcinoma. (ekstern lenke)
• Mauland, Karen Klepsland; Wik, Elisabeth; Høivik, Erling Andre et al. (2016). Aneuploidy related transcriptional changes in endometrial cancer link low expression of chromosome 15q genes to poor survival. (ekstern lenke)
• Valla, Marit; Vatten, Lars Johan; Engstrøm, Monica J et al. (2016). Molecular subtypes of breast cancer: Long-term incidence trends and prognostic differences. (ekstern lenke)
• Reisæter, Lars Anders Rokne; Fütterer, Jurgen; Halvorsen, Ole Johan et al. (2015). 1.5-T multiparametric MRI using PI-RADS: a region by region analysis to localize the index-tumor of prostate cancer in patients undergoing prostatectomy. (ekstern lenke)
• Nygård, Yngve; Haukaas, Svein Andreas; Eide, Geir Egil et al. (2015). Prostate cancer antigen-3 (PCA3) and PCA3-based nomograms in the diagnosis of prostate cancer: an external validation of Hansen's nomogram on a Norwegian cohort. (ekstern lenke)
• Von Dobschuetz, Ernst; Leijon, Helena; Schalin-Jäntti, Camilla et al. (2015). A registry-based study of thyroid paraganglioma: histologic and genetic characteristics. (ekstern lenke)
• Barrett, Jennifer H.; Taylor, John C.; Bright, C et al. (2015). Fine mapping of genetic susceptibility loci for melanoma reveals a mixture of single variant and multiple variant regions. (ekstern lenke)
• Stefansson, Ingunn; Ræder, Maria B; Wik, Elisabeth et al. (2015). Increased angiogenesis is associated with a 32-gene expression signature and 6p21 amplification in aggressive endometrial cancer. (ekstern lenke)
• Knappskog, Stian; Berge, Elisabet Ognedal; Chrisanthar, Ranjan et al. (2015). Concomitant inactivation of the p53- and pRB- functional pathways predicts resistance to DNA damaging drugs in breast cancer in vivo. (ekstern lenke)
• Ahmed, Lavina; Nalwoga, Hawa; Arnes, Jarle et al. (2015). Increased tumor cell expression of Axl is a marker of aggressive features in breast cancer among African women. (ekstern lenke)
• Kraby, Maria Ryssdal; Krüger, Kristi; Opdahl, Signe et al. (2015). Microvascular proliferation in luminal A and basal-like breast cancer subtypes. (ekstern lenke)
• Law, Matthew H.; Bishop, D. Timothy; Lee, Jeffrey E. et al. (2015). Genome-wide meta-analysis identifies five new susceptibility loci for cutaneous malignant melanoma. (ekstern lenke)
• Hofvind, Solveig; Holen, Åsne Sørlien; Aas, Turid et al. (2015). Women treated with breast conserving surgery do better than those with mastectomy independent of detection mode, prognostic and predictive tumor characteristics. (ekstern lenke)
• Biermann, Martin; Kråkenes, Jostein; Brauckhoff, Katrin et al. (2015). Post-PET ultrasound improves specificity of 18F-FDG-PET for recurrent differentiated thyroid cancer while maintaining sensitivity. (ekstern lenke)
• Moshina, Nataliia; Ursin, Giske; Hoff, Solveig Roth et al. (2015). Mammographic density and histopathologic characteristics of screen-detected tumors in the Norwegian Breast Cancer Screening Program. (ekstern lenke)
• Bredholt, Geir; Mannelqvist, Monica; Stefansson, Ingunn et al. (2015). Tumor necrosis is an important hallmark of aggressive endometrial cancer and associates with hypoxia, angiogenesis and inflammation responses. (ekstern lenke)
• Nygård, Yngve; Haukaas, Svein Andreas; Halvorsen, Ole Johan et al. (2014). A positive real-time elastography is an independent marker for detection of high-risk prostate cancers in the primary biopsy setting. (ekstern lenke)
• Haldorsen, Ingfrid S.; Stefansson, Ingunn; Grüner, Renate et al. (2014). Increased microvascular proliferation is negatively correlated to tumour blood flow and is associated with unfavourable outcome in endometrial carcinomas. (ekstern lenke)
• Ladstein, Rita Grude; Bachmann, Ingeborg M.; Straume, Oddbjørn et al. (2014). Nestin expression is associated with aggressive cutaneous melanoma of the nodular type. (ekstern lenke)
• Ojesina, Akinyemi; Lichtenstein, Lee; Freeman, Samuel S. et al. (2014). Landscape of genomic alterations in cervical carcinomas. (ekstern lenke)
• Lia, Wenliang; Ai, Nanping; Wang, Suming et al. (2014). GRK3 is essential for metastatic cells and promotes prostate tumor progression. (ekstern lenke)
• Mackay, Helen; Eisenhauer, Elizabeth A.; Kamel-Reid, Suzanne et al. (2014). Molecular determinants of outcome with mammalian target of rapamycin inhibition in endometrial cancer. (ekstern lenke)
• Werner, Henrica Maria Johanna; Trovik, Jone; Halle, Mari Kyllesø et al. (2014). Stathmin Protein Level, a Potential Peredictive Marker for Taxane Treatment Response in Endometrial Cancer. (ekstern lenke)
• Rogers, Michael S.; Novak, Katherine; Zurakowski, David et al. (2014). Spontaneous reversion of the angiogenic phenotype to a nonangiogenic and dormant state in human tumors. (ekstern lenke)
• Tangen, Ingvild Løberg; Krakstad, Camilla; Halle, Mari Kyllesø et al. (2014). Switch in FOXA1 status associates with endometrial cancer progression. (ekstern lenke)
• Iles, Mark M.; Bishop, D. Timothy; Taylor, John C. et al. (2014). The effect on melanoma risk of genes previously associated with telomere length. (ekstern lenke)
• Hellesøy, Monica; Blois, Anna; Tiron, Crina Elena et al. (2014). Akt1 activity regulates vessel maturation in a tissue engineering model of angiogenesis. (ekstern lenke)
• Wik, Elisabeth; Trovik, Jone; Kusonmano, Kanthida et al. (2014). Endometrial Carcinoma Recurrence Score (ECARS) validates to identify aggressive disease and associates with markers of epithelial-mesenchymal transition and PI3K alterations. (ekstern lenke)
• Shahrabi-Farahani, Shokoufeh; Wang, Lili; Zwaans, Bernadette MM et al. (2014). Neuropilin 1 expression correlates with differentiation status of epidermal cells and cutaneous squamous cell carcinomas. (ekstern lenke)
• Mannelqvist, Monica; Wik, Elisabeth; Stefansson, Ingunn et al. (2014). An 18-Gene signature for vascular invasion is associated with aggressive features and reduced survival in breast cancer. (ekstern lenke)
• Chen, Ying; Klingen, Tor Audun; Wik, Elisabeth et al. (2014). Breast cancer stromal elastosis is associated with mammography screening detection, low Ki67 expression and favourable prognosis in a population-based study. (ekstern lenke)
• Knutsvik, Gøril; Stefansson, Ingunn; Aziz, Sura Mohammed et al. (2014). Evaluation of Ki67 expression across distinct categories of breast cancer specimens: A Population-based study of matched surgical specimens, core needle biopsies and tissue microarrays. (ekstern lenke)
• Arnesen, Thomas; Glomnes, Nina; Strømsøy, Siri S. et al. (2013). Outcome after surgery for primary hyperaldosteronism may depend on KCNJ5 tumor mutation status: a population-based study from Western Norway. (ekstern lenke)
• Ozhand, Ali; Lee, Eunjung; Wu, Anna H. et al. (2013). Variation in inflammatory cytokine/growth-factor genes and mammographic density in premenopausal women aged 50-55. (ekstern lenke)
• Hoem, Dag; Straume, Oddbjørn; Immervoll, Heike et al. (2013). Vascular proliferation is associated with survival in pancreatic ductal adenocarcinoma. (ekstern lenke)
• Haldorsen, Ingfrid S.; Grüner, Renate; Husby, Jenny Hild Aase et al. (2013). Dynamic contrast-enhanced MRI in endometrial carcinoma identifies patients at increased risk of recurrence. (ekstern lenke)
• Trovik, Jone; Wik, Elisabeth; Werner, Henrica Maria Johanna et al. (2013). Hormone receptor loss in endometrial carcinoma curettage predicts lymph node metastasis and poor outcome in prospective multicentre trial. (ekstern lenke)
• Klingen, Tor Audun; Chen, Ying; Suhrke, Pål et al. (2013). Expression of thyroid transcription factor-1 is associated with a basal-like phenotype in breast carcinomas. (ekstern lenke)
• Iles, Mark M.; Law, Matthew H.; Stacey, Simon N. et al. (2013). A variant in FTO shows association with melanoma risk not due to BMI. (ekstern lenke)
• Veinalde, Rūta; Ozola, Aija; Azarjana, Kristine et al. (2013). Analysis of Latvian familial melanoma patients shows novel variants in the noncoding regions of CDKN2A and that the CDK4 mutation R24H is a founder mutation. (ekstern lenke)
• Wik, Elisabeth; Ræder, Maria B; Krakstad, Camilla et al. (2013). Lack of estrogen receptor-alpha is associated with epithelial-mesenchymal transition and PI3K alterations in endometrial carcinoma. (ekstern lenke)
• Werner, Henrica Maria Johanna; Berg, Anna; Wik, Elisabeth et al. (2013). ARID1A loss is prevalent in endometrial hyperplasia with atypia and low-grade endometrioid carcinomas. (ekstern lenke)
• Pedersen, Torbjørn Østvik; Blois, Anna; Xing, Zhe et al. (2013). Endothelial microvascular networks affect gene-expression profiles and osteogenic potential of tissue-engineered constructs. (ekstern lenke)
• Engstrøm, Monica J; Opdahl, Signe; Hagen, Anne Irene et al. (2013). Molecular subtypes, histopathological grade and survival in a historic cohort of breast cancer patients. (ekstern lenke)
• Catena, Raúl; Bhattacharya, Nandita; El Rayes, Tina et al. (2013). Bone marrow-derived Gr1(+) cells can generate a metastasis-resistant microenvironment via induced secretion of thrombospondin-1. (ekstern lenke)
• Wik, Elisabeth; Birkeland, Even; Trovik, Jone et al. (2013). High phospho-stathmin(Serine38) expression identifies aggressive endometrial cancer and suggests an association with PI3K inhibition. (ekstern lenke)
• Moestue, Siver Andreas; Huuse, Else Marie; Lindholm, Evita Maria et al. (2013). Low-molecular contrast agent DCE-MRI and DW-MRI in early assessment of bevacizumab treatment in breast cancer xenografts. (ekstern lenke)
• Ræder, Maria B; Birkeland, Even; Trovik, Jone et al. (2013). Integrated genomic analysis of the 8q24 amplification in endometrial cancers identifies ATAD2 as essential to MYC-dependent cancers. (ekstern lenke)
• Puntervoll, Hanne Eknes; Yang, Xiaohong R.; Vetti, Hildegunn Høberg et al. (2013). Melanoma prone families with CDK4 germline mutation: phenotypic profile and associations with MC1R variants. (ekstern lenke)
• Garcia-Dios, Diego A; Lambrechts, Diether; Coenegrachts, Lieve et al. (2013). High-throughput interrogation of PIK3CA, PTEN, KRAS, FBXW7 and TP53 mutations in primary endometrial carcinoma. (ekstern lenke)
• Schuster, Cornelia; Eikesdal, Hans Petter; Puntervoll, Hanne Eknes et al. (2012). Clinical efficacy and safety of bevacizumab monotherapy in patients with metastatic melanoma: predictive importance of induced early hypertension. (ekstern lenke)
• Krakstad, Camilla; Trovik, Jone; Wik, Elisabeth et al. (2012). Loss of GPER identifies new targets for therapy among a subgroup of ER alpha-positive endometrial cancer patients with poor outcome. (ekstern lenke)
• Helsing, Per; Nymoen, Dag Andre; Rootwelt, Helge et al. (2012). MC1R, ASIP, TYR, and TYRP1 gene variants in a population-based series of multiple primary melanomas. (ekstern lenke)
• Straume, Oddbjørn; Shimamura, Takeshi; Lampa, Michael J.G. et al. (2012). Suppression of heat shock protein 27 induces long-term dormancy in human breast cancer. (ekstern lenke)
• Arnes, Jarle; Stefansson, Ingunn Marie; Straume, Oddbjørn et al. (2012). Vascular proliferation is a prognostic factor in breast cancer. (ekstern lenke)
• Moen, Ingrid; Jevne, Alison Charlotte; Wang, Jian et al. (2012). Gene expression in tumor cells and stroma in dsRed 4T1 tumors in eGFP-expressing mice with and without enhanced oxygenation. (ekstern lenke)
• Lindholm, Evita Maria; Kristian, Alexandr; Nalwoga, Hawa et al. (2012). Effect of antiangiogenic therapy on tumor growth, vasculature and kinase activity in basal- and luminal-like breast cancer xenografts. (ekstern lenke)
• Brauckhoff, Michael; Varhaug, Jan Erik; Hauptmann, Steffen et al. (2012). Peritoneal carcinosis in apparently benign cortisol producing adrenal adenoma >= 5 cm in diameter: the need of regular postoperative surveillance. (ekstern lenke)
• Ladstein, Rita Grude; Bachmann, Ingeborg M.; Straume, Oddbjørn et al. (2012). Tumor necrosis is a prognostic factor in thick cutaneous melanoma. (ekstern lenke)
• Huuse, Else Marie; Moestue, Siver Andreas; Lindholm, Evita Maria et al. (2012). In vivo MRI and histopathological assessment of tumor microenvironment in luminal-like and basal-like breast cancer xenografts. (ekstern lenke)
• Ladstein, Rita Grude; Bachmann, Ingeborg M.; Straume, Oddbjørn et al. (2012). Prognostic Importance of the Mitotic Marker Phosphohistone H3 in Cutaneous Nodular Melanoma. (ekstern lenke)
• Birkeland, Even; Wik, Elisabeth; Mjøs, Siv et al. (2012). KRAS gene amplification and overexpression but not mutation associates with aggressive and metastatic endometrial cancer. (ekstern lenke)
• Mannelqvist, Monica; Stefansson, Ingunn Marie; Wik, Elisabeth et al. (2012). Lipocalin 2 expression is associated with aggressive features of endometrial cancer. (ekstern lenke)
• Nygård, Yngve; Haukaas, Svein Andreas; Waage, Jo Erling Riise et al. (2012). Combination of real-time elastography and urine prostate cancer gene 3 (PCA3) detects more than 97 % of significant prostate cancers. (ekstern lenke)
• Ellingjord-Dale, Merete; Lee, Eunjung; Couto, Elisabeth et al. (2012). Polymorphisms in hormone metabolism and growth factor genes and mammographic density in Norwegian postmenopausal hormone therapy users and non-users. (ekstern lenke)
• Krüger, Kristi; Stefansson, Ingunn Marie; Collett, Karin et al. (2012). Microvessel proliferation by co-expression of endothelial nestin and Ki-67 is associated with a basal-like phenotype and aggressive features in breast cancer. (ekstern lenke)
• Ke, Xisong; Li, Wencheng; Hovland, Randi et al. (2011). Reprogramming of cell junction modules during stepwise epithelial to mesenchymal transition and accumulation of malignant features in vitro in a prostate cell model. (ekstern lenke)
• Mauland, Karen Klepsland; Trovik, Jone; Wik, Elisabeth et al. (2011). High BMI is significantly associated with positive progesterone receptor status and clinico-pathological markers for non-aggressive disease in endometrial cancer. (ekstern lenke)
• Mannelqvist, Monica; Stefansson, Ingunn Marie; Bredholt, Geir et al. (2011). Gene Expression Patterns Related to Vascular Invasion and Aggressive Features in Endometrial Cancer. (ekstern lenke)
• Vandenput, Ingrid; Trovik, Jone; Leunen, Karin et al. (2011). Evolution in endometrial cancer evidence from an immunohistochemical study. (ekstern lenke)
• Hegen, Anja; Blois, Anna; Tiron, Crina Elena et al. (2011). Efficient in vivo vascularization of tissue-engineering scaffolds. (ekstern lenke)
• Akslen, Lars A.; Straume, Oddbjørn; Geisler, Stephanie et al. (2011). Glomeruloid microvascular proliferation is associated with lack of response to chemotherapy in breast cancer. (ekstern lenke)
• Trovik, Jone; Wik, Elisabeth; Stefansson, Ingunn Marie et al. (2011). Stathmin Overexpression Identifies High-Risk Patients and Lymph Node Metastasis in Endometrial Cancer. (ekstern lenke)
• Myklebust, Line Merethe; Akslen, Lars A.; Varhaug, Jan Erik et al. (2011). Receptor for Activated Protein C Kinase 1 (RACK1) Is Overexpressed in Papillary Thyroid Carcinoma. (ekstern lenke)
• Barrett, Jennifer H.; Iles, MM; Harland, M et al. (2011). Genome-wide association study identifies three new melanoma susceptibility loci. (ekstern lenke)
• Nalwoga, Hawa; Arnes, Jarle; Stefansson, Ingunn Marie et al. (2011). Vascular proliferation is increased in basal-like breast cancer. (ekstern lenke)
• Gjerdrum, Christine; Tiron, Crina Elena; Høiby, Torill et al. (2010). Axl is an essential epithelial-to-mesenchymal transition-induced regulator of breast cancer metastasis and patient survival. (ekstern lenke)
• Nalwoga, Hawa; Arnes, Jarle; Wabinga, Henry et al. (2010). Expression of aldehyde dehydrogenase a (ALDH1) is associated with basal-like markers and features of aggressive tumors in African breast cancer. (ekstern lenke)
• Ladstein, Rita Grude; Bachmann, Ingeborg M.; Straume, Oddbjørn et al. (2010). Ki-67 expression is superior to mitotic count and novel proliferation markers PHH3, MCM4 and mitosin as a prognostic factor in thick cutaneous melanoma. (ekstern lenke)
• Blows, Fiona M.; Driver, Kristy E.; Schmidt, Marjanka K. et al. (2010). Subtyping of breast cancer by immunohistochemistry to investigate a relationship between subtype and short and long term survival: a collaborative analysis of data for 10,159 cases from 12 studies. (ekstern lenke)
• Klingen, Tor Audun; Klaasen, Herman; Chen, Ying et al. (2009). Secondary breast cancer: a 5-year population-based study with review of the literature. (ekstern lenke)
• Arnes, Jarle; Begin, LR; Brunet, JS et al. (2009). Expression of epidermal growth factor receptor in relation to BRCA1 status, basal-like markers and prognosis in breast cancer. (ekstern lenke)
• Rakha, Emad A.; Elsheikh, Somaia E.; Aleskandarany, Muhammed A. et al. (2009). Triple-Negative Breast Cancer: Distinguishing between Basal and Nonbasal Subtypes. (ekstern lenke)
• Moen, Ingrid; Øyan, Anne Margrete; Kalland, Karl-Henning et al. (2009). Hyperoxic treatment induces mesenchymal to epithelial transition in a rat adenocarcinoma model. (ekstern lenke)
• Salvesen, Helga Birgitte; Carter, Scott L.; Mannelqvist, Monica et al. (2009). Integrated genomic profiling of endometrial carcinoma associates aggressive tumors with indicators of PI3 kinase activation. (ekstern lenke)
• Fluge, Øystein; Gravdal, K; Carlsen, E et al. (2009). Expression of EZH2 and Ki-67 in colorectal cancer and associations with treatment response and prognosis. (ekstern lenke)
• Ke, Xisong; Qu, Yi; Rostad, Kari et al. (2009). Genome-wide profiling of histone H3 lysine 4 and lysine 27 trimethylation reveals an epigenetic signature in prostate carcinogenesis. (ekstern lenke)
• Mæhle, BO; Mæhle, Bjørn Ove; Collett, Karin et al. (2009). Estrogen receptor β– an independent prognostic marker in estrogen receptor α and progesterone receptor-positive breast cancer?. (ekstern lenke)
• Etemadmoghadam, Dariush; deFazio, Anna; Beroukhim, Rameen et al. (2009). Integrated Genome-Wide DNA Copy Number and Expression Analysis Identifies Distinct Mechanisms of Primary Chemoresistance in Ovarian Carcinomas. (ekstern lenke)
• Rostad, Kari; Hellwinkel, Olaf JC; Haukaas, Svein Andreas et al. (2009). TMPRSS2:ERG fusion transcripts in urine from prostate cancer patients correlate with a less favorable prognosis. (ekstern lenke)
• Klingen, Tor A; Klaasen, Heman; Aas, Hans et al. (2009). Secondary breast cancer: a 5-year population-based study with review of the literature. (ekstern lenke)
• Pjanova, Dace; Molven, Anders; Akslen, Lars A. et al. (2009). Identification of a CDK4 R24H mutation-positive melanoma family by analysis of early-onset melanoma patients in Latvia. (ekstern lenke)
• Bhriain, Hannah Ni; Trovik, Jone; Wik, Elisabeth et al. (2009). Plasma calprotectin concentrations in women with endometrial carcinoma. (ekstern lenke)
• Mannelqvist, Monica; Stefansson, Ingunn Marie; Salvesen, Helga Birgitte et al. (2009). Importance of tumour cell invasion in blood and lymphatic vasculature among patients with endometrial carcinoma. (ekstern lenke)
• Wik, Elisabeth; Trovik, Jone; Iversen, Ole-Erik et al. (2009). Deoxyribonucleic acid ploidy in endometrial carcinoma: a reproducible and valid prognostic marker in a routine diagnostic setting. (ekstern lenke)
• Naumov, George N.; Nilsson, Monique B.; Cascone, Tina et al. (2009). Combined vascular endothelial growth factor receptor and epidermal growth factor receptor (EGFR) blockade inhibits tumor growth in xenograft models of EGFR inhibitor resistance. (ekstern lenke)
• Gravdal, Karsten; Halvorsen, Ole Johan; Haukaas, Svein Andreas et al. (2009). Proliferation of immature tumor vessels is a novel marker of clinical progression in prostate cancer. (ekstern lenke)
• Kang, Soo-Young; Halvorsen, Ole Johan; Gravdal, Karsten et al. (2009). Prosaposin inhibits tumor metastasis via paracrine and endocrine stimulation of stromal p53 and Tsp-1. (ekstern lenke)
• Bruland, Ove; Fluge, Øystein; Akslen, Lars A. et al. (2009). Inverse correlation between PDGFC expression and lymphocyte infiltration in human papillary thyroid carcinomas. (ekstern lenke)
• Dutt, Amit; Salvesen, Helga; Chent, Tzu-Hsiu et al. (2008). Drug-sensitive FGFR2 mutations in endometrial carcinoma. (ekstern lenke)
• Lin, Biaoyang; Utleg, Angelita G.; Gravdal, Karsten et al. (2008). WDR19 expression is increased in prostate cancer compared with normal cells, but low-intensity expression in cancers is associated with shorter time to biochemical failures and local recurrence. (ekstern lenke)
• Engelsen, Ingeborg Bøe; Stefansson, Ingunn Marie; Beroukhim, Rameen et al. (2008). HER-2/neu expression is associated with high tumor cell proliferation and aggressive phenotype in a population based patient series of endometrial carcinomas. (ekstern lenke)
• Arnes, Jarle; Collett, Karin; Akslen, Lars A. (2008). Lesson of the Month - Independent prognostic value of the basal-like phenotype of breast cancer and associations with EGFR and candidate stem cell marker BMI-1. (ekstern lenke)
• Helsing, Per; Nyrnoen, Dag André; Ariansen, Sarah et al. (2008). Population-based prevalence of CDKN2A and CDK4 mutations in patients with multiple primary melanomas. (ekstern lenke)
• Borkamo, Erling Dahl; Fluge, Øystein; Mella, Olav et al. (2008). Hyperthermia improves the antitumour effect of metronomic cyclophosphamide in a rat transplantable brain tumour. (ekstern lenke)
• Bachmann, Ingeborg M.; Puntervoll, Hanne Eknes; Otte, Arie P. et al. (2008). Loss of BMI-1 expression is associated with clinical progress of malignant melanoma. (ekstern lenke)
• Akslen, Lars A.; Puntervoll, Hanne Eknes; Bachmann, Ingeborg M. et al. (2008). Mutation analysis of the EGFR-NRAS-BRAF pathway in melanomas from black Africans and other subgroups of cutaneous melanoma. (ekstern lenke)
• Engelsen, Ingeborg Bøe; Mannelqvist, Monica; Stefansson, Ingunn Marie et al. (2008). Low BMI-1 expression is associated with an activated BMI-1-driven signature, vascular invasion, and hormone receptor loss in endometrial carcinoma. (ekstern lenke)
• Bachmann, Ingeborg M.; Ladstein, Rita Grude; Straume, Oddbjørn et al. (2008). Tumor necrosis is associated with increased alphavbeta3 integrin expression and poor prognosis in nodular cutaneous melanomas. (ekstern lenke)
• Engelsen, Ingeborg Bøe; Stefansson, IM; Akslen, Lars A. et al. (2008). GATA3 expression in estrogen receptor alpha-negative endometrial carcinomas identifies aggressive tumors with high proliferation and poor patient survival. (ekstern lenke)
• Nalwoga, Hawa; Arnes, Jarle; Wabinga, Henry et al. (2008). Expression of EGFR and c-kit is associated with the basal-like phenotype in breast carcinomas of African women. (ekstern lenke)
• Ke, Xisong; Qu, Yi; Goldfinger, Naomi et al. (2008). Epithelial to Mesenchymal Transition of a Primary Prostate Cell Line with Switches of Cell Adhesion Modules but without Malignant Transformation. (ekstern lenke)
• Halvorsen, Ole Johan; Rostad, Kari; Øyan, Anne Margrete et al. (2007). Increased expression of sim2-s protein is a novel marker of aggressive prostate cancer. (ekstern lenke)
• Nalwoga, Hawa; Arnes, Jarle; Wabinga, Henry et al. (2007). Frequency of the basal-like phenotype in African breast cancer. (ekstern lenke)
• Tischkowitz, Marc; Brunet, Jean-Sébastien; Bégin, Louis R. et al. (2007). Use of immunohistochemical markers can refine prognosis in triple negative breast cancer. (ekstern lenke)
• Gravdal, Karsten; Halvorsen, Ole Johan; Haukaas, Svein Andreas et al. (2007). A Switch from E-Cadherin to N-Cadherin Expression Indicates Epithelial to Mesenchymal Transition and Is of Strong and Independent Importance for the Progress of Prostate Cancer. (ekstern lenke)
• Petersen, Kjell; Øyan, Anne Margrete; Rostad, Kari et al. (2007). Comparison of nucleic acid targets prepared from total RNA or poly(A) RNA for DNA oligonucleotide microarray hybridization. (ekstern lenke)
• Rostad, Kari; Mannelqvist, Monica; Halvorsen, Ole Johan et al. (2007). ERG upregulation and related ETS transcription factors in prostate cancer. (ekstern lenke)
• Gravdal, Karsten; Halvorsen, Ole Johan; Haukaas, Svein Andreas et al. (2006). Expression of bFGF/FGFR-1 and vascular proliferation related to clinicopathologic features and tumor progress in localized prostate cancer. (ekstern lenke)
• Naumov, George N.; Akslen, Lars A.; Folkman, Judah (2006). Role of angiogenesis in human tumor dormancy - Animal models of the angiogenic switch. (ekstern lenke)
• Engeland, Anders; Tretli, Steinar; Akslen, Lars Andreas et al. (2006). Body size and thyroid cancer in two million Norwegian men and women. (ekstern lenke)
• Fluge, Øystein; Bruland, Ove; Akslen, Lars A. et al. (2006). Gene expression in poorly differentiated papillary thyroid carcinomas. (ekstern lenke)
• Sørlie, Therese; Perou, Charles M.; Fan, Cheng et al. (2006). Gene expression profiles do not consistently predict the clinical treatment response in locally advanced breast cancer. (ekstern lenke)
• Engelsen, Ingeborg; Stefansson, Ingunn Marie; Akslen, Lars A. et al. (2006). Pathologic expression of p53 or p16 in preoperative curettage specimens identifies high-risk endometrial carcinomas. (ekstern lenke)
• Stefansson, Ingunn Marie; Salvesen, Helga; Akslen, Lars A. (2006). Loss of p63 and cytokeratin 5/6 expression is associated with more aggressive tumors in endometrial carcinoma patients. (ekstern lenke)
• Stefansson, Ingunn Marie; Salvesen, Helga; Akslen, Lars A. (2006). Vascular proliferation is important for clinical progress of endometrial cancer. (ekstern lenke)
• Naumov, George N.; Bender, Elise; Zurakowski, David et al. (2006). A model of human tumor dormancy: An angiogenic switch from the nonangiogenic phenotype. (ekstern lenke)
• Haukaas, Svein Andreas; Halvorsen, Ole Johan; Dæhlin, Lars et al. (2006). Is preoperative serum prostate-specific antigen level significantly related to clinical recurrence after radical 14 retropubic prostatectomy for localized prostate cancer?. (ekstern lenke)
• Bachmann, Ingeborg Margrethe; Halvorsen, Ole Johan; Collett, Karin et al. (2006). EZH2 expression is associated with high proliferation rate and aggressive tumor subgroups in cutaneous melanoma and cancers of the endometrium, prostate, and breast. (ekstern lenke)
• Collett, Karin; Eide, Geir Egil; Arnes, Jarle et al. (2006). Expression of enhancer of zeste homologue 2 is significantly associated with increased tumor cell proliferation and is a marker of aggressive breast cancer. (ekstern lenke)
• Halvorsen, Ole Johan; Øyan, Anne Margrete; Bø, Trond Hellem et al. (2005). Gene expression profiles in prostate cancer: Association with patient subgroups and tumour differentiation. (ekstern lenke)
• Bachmann, Ingeborg; Straume, Oddbjørn; Puntervoll, Hanne Eknes et al. (2005). Importance of P-cadherin, beta-catenin, and Wnt5a/frizzled for progression of melanocytic tumors and prognosis in cutaneous melanoma. (ekstern lenke)
• Straume, Oddbjørn; Akslen, Lars A. (2005). Strong expression of ID1 protein is associated with decreased survival, increased expression of ephrin-A1/EPHA2, and reduced thrombospondin-1 in malignant melanoma. (ekstern lenke)
• Sharma, Praveen; Sahni, Narinder S; Tibshirani, Robert et al. (2005). Early detection of breast cancer based on gene-expression patterns in peripheral blood cells. (ekstern lenke)
• Salvesen, Helga; Kumar, Rajiv; Stefansson, Ingunn Marie et al. (2005). Low frequency of BRAF and CDKN2A mutations in endometrial cancer. (ekstern lenke)
• Sharma, Praveen; Sahni, Narinder S; Tibshirani, Robert et al. (2005). Early detection of brest cancer based on gene-expression patterns in peripheral blood cells. (ekstern lenke)
• Akslen, Lars A.; Angelini, Sabrina; Straume, Oddbjørn et al. (2005). BRAF and NRAS mutations are frequent in nodular melanoma but are not associated with tumor cell proliferation or patient survival. (ekstern lenke)
• Molven, Anders; Grimstvedt, Magne B.; Steine, Solrun et al. (2005). A large Norwegian family with inherited malignant melanoma, multiple atypical nevi, and CDK4 mutation. (ekstern lenke)
• Collett, Karin; Stefansson, Ingunn Marie; Eide, Johan et al. (2005). A basal epithelial phenotype is more frequent in interval breast cancers compared with screen detected tumors. (ekstern lenke)
• Gjengstø, Peder; Paus, Elisabeth; Halvorsen, OJ et al. (2005). Predictors of prostate cancer evaluated by receiver operating characteristics partial area index: a prospective institutional study. (ekstern lenke)
• Salvesen, Helga; Stefansson, Ingunn Marie; Kretzschmar, EI et al. (2004). Significance of PTEN alterations in endometrial carcinoma: a population-based study of mutations, promoter methylation and PTEN protein expression. (ekstern lenke)
• Macdonald, ND; Salvesen, Helga; Ryan, A et al. (2004). Molecular differences between RER+ and RER- sporadic endometrial carcinomas in a large population-based series. (ekstern lenke)
• Nielsen, TO; Hsu, FD; Jensen, K et al. (2004). Immunohistochemical and Clinical Characterization of the Basal-like Subtype of Invasive Breast Carcinoma. (ekstern lenke)
• Foulkes, WD; Brunet, JS; Stefansson, Ingunn Marie et al. (2004). The prognostic implication of the basal-like (cyclin E-high/p27(low)/p53(+)/glomeruloid-microvascular-proliferation(+)) phenotype of BRCA1-related breast cancer. (ekstern lenke)
• Bachmann, Ingeborg; Straume, Oddbjørn; Akslen, Lars A. (2004). Altered expression of cell cycle regulators Cyclin D1, p14, p16, CDK4 and Rb in nodular melanomas. (ekstern lenke)
• Stefansson, Ingunn Marie; Salvesen, Helga; Akslen, Lars A. (2004). Prognostic impact of histological grade and vascular invasion compared with tumor cell proliferation in endometrial carcinoma of endometrioid type. (ekstern lenke)
• Stefansson, Ingunn Marie; Salvesen, Helga; Akslen, Lars A. (2004). Prognostic impact of alterations in P-cadherin expression and related cell adhesion markers in endometrial cancer. (ekstern lenke)
• Eikesdal, Hans Petter; Straume, Oddbjørn; Akslen, Lars A. et al. (2004). Karnydanning og tumorkar som mål for kreftterapi. (ekstern lenke)
• Geisler, Stephanie; Børresen-Dale, Anne-Lise; Johnsen, Hilde et al. (2003). TP53 gene mutations predict the response to neoadjuvant treatment with 5-fluorouracil and mitomycin in locally advanced breast cancer. (ekstern lenke)
• Gjengstø, Peder; Halvorsen, Ole J.; Akslen, Lars A. et al. (2003). Benign growth of different prostate zones in aging men with slightly elevated PSA in whom prostate cancer has been excluded: a prospective study of 510 patients. (ekstern lenke)
• Foulkes, WD; Stefansson, Ingunn Marie; Chappuis, PO et al. (2003). Germline BRCA1 mutations and a basal epithelial phenotype in breast cancer. (ekstern lenke)
• Halford, SE; Sawyer, EJ; Lambros, MB et al. (2003). MSI-low, a real phenomenon which varies in frequency among cancer types. (ekstern lenke)
• Alexander-Sefre, F; Salvesen, Helga B.; Abeler, N et al. (2003). Molecular assessment of depth of myometrial invasion in stage I endometrial cancer: a model based on K-ras mutation analysis. (ekstern lenke)
• Halvorsen, Ole J.; Haukaas, Sven; Akslen, Lars A. (2003). Combined loss of PTEN and p27 expression is associated with tumor cell proliferation by Ki-67 and increased risk of recurrent disease in localized prostate cancer. (ekstern lenke)
• Salvesen, Helga B.; Gulluoglu, Mine G; Stefansson, Ingunn Marie et al. (2003). Significance of CD 105 expression for tumour angiogenesis and prognosis in endometrial carcinomas. (ekstern lenke)
• Aas, Turid; Geisler, Stephanie; Eide, Geir Egil et al. (2003). Predictive value of tumour cell proliferation in locally advanced breast cancer treated with neoadjuvant chemotherapy. (ekstern lenke)
• Salvesen, Helga Birgitte; Akslen, Lars A. (2002). Molecular pathogenesis and prognostic factors in endometrial carcinoma. (ekstern lenke)
• Stefansson, Ingunn Marie; Akslen, Lars A.; MacDonald, N et al. (2002). Loss of hMSH2 and hMSH6 expression is frequent in sporadic endometrial carcinomas with microsatellite instability: a population-based study. (ekstern lenke)
• Salvesen, Helga B.; Stefansson, Ingunn Marie; Kalvenes, May Britt et al. (2002). Loss of PTEN expression is associated with metastatic disease in patients with endometrial carcinoma. (ekstern lenke)
• Paessler, M; Kreisel, FH; Livolsi, VA et al. (2002). Can we rely on pathologic parameters to define conservative treatment of papillary thyroid carcinoma?. (ekstern lenke)
• Mbonde, MP; Amir, H; Akslen, Lars A. et al. (2001). Expression of oestrogen and progesterone receptorss, Ki-67, p53 and BCL-2 proteins, cathepsin D, urokinase plasminogen activator and urokinase plasminogen activator-receptors in carcinomas of the female breast in an African poplation. (ekstern lenke)
• Halvorsen, Ole J.; Haukaas, Sven; Høisæter, Per Åge et al. (2001). Maximum Ki-67 staining in prostate cancer provides independent prognostic information after radical prostatectomy. (ekstern lenke)
• Frich, Lars; Glattre, Eystein; Akslen, Lars A. (2001). Familial occurrence of nonmedullary thyroid cancer: a population-based study of 5673 first-degree relatives of thyroid cancer patients from Norway. (ekstern lenke)
• Fluge, Øystein; Haugen, Dagny R. Faksvåg; Akslen, Lars A. et al. (2001). Expression and alternative splicing of c-ret RNA in papillary thyroid carcinomas. (ekstern lenke)
• Perou, CM; Sørlie, T; Eisen, MB et al. (2000). Molecular portraits of human breast tumours. (ekstern lenke)
• Vuhahula, E; Straume, Oddbjørn; Akslen, Lars A. (2000). Frequent loss of p16 protein expression and high proliferative activity (Ki-67) in malignant melanoma from black Africans. (ekstern lenke)
• Hove, Leif M; Akslen, Lars A. (1999). Clinicopathological characteristics of melanomas of the hand. (ekstern lenke)
• Haugen, Dagny R. Faksvåg; Lillehaug, JR; Akslen, Lars A. (1999). Enhanced expression of EGF-receptor and low frequency of ras mutations in X-ray-induced rat thyroid tumours. (ekstern lenke)
• Lønning, Per Eystein; Johnsen, H; Geisler, Stephanie et al. (1999). TP53 as a predictor of response to chemotherapy in breast cancer. (ekstern lenke)
• Salvesen, Helga; Iversen, Ole-Erik; Akslen, Lars A. (1999). Prognostic value of tumor angiogenesis, Ki67, p53 and p21 protein expression - a population based endometrial carcinoma study. (ekstern lenke)
• Das, S; MacDonald, N; Ryan, A et al. (1999). The PTEN gene is methylated in endometrial carcinoma and associated with advanced disease and microsattelite instability. (Abs. no. 207). (ekstern lenke)
• Salvesen, Helga; Iversen, Ole-Erik; Akslen, Lars A. (1999). Prognostic significance of tumor angiogenesis, Ki-67, p53 and p21 expression - a population-based endometrial carcinoma study. (ekstern lenke)
• Hove, Leif M; Akslen, Lars A. (1999). Clinicopathological characteristics of melanomas of the hand. (ekstern lenke)
• Salvesen, Helga; Akslen, Lars A. (1999). Significance of tumor associated macrophages, VEGF and TSP-1 for angiogenesis and prognosis of endometrial carcinoma. (ekstern lenke)
• Straume, Oddbjørn; Salvesen, Helga; Akslen, Lars A. (1999). Angiogenesis is prognostically important in vertical growth phase melanomas. (ekstern lenke)
• Lønning, Per Eystein; Johnsen, H; Geisler, Stephanie et al. (1999). TP53 as a predictor of response to chemotherpy in breast cancer. (ekstern lenke)
• Salvesen, Helga; Akslen, Lars A. (1999). Significance of tumor associated macrophages. VEGF and TSP-1 expression for tumor angiogenesis and prognosis in endometrial carcinomas. (ekstern lenke)
• Salvesen, Helga; Iversen, Ole-Erik; Akslen, Lars A. (1999). Prognostic significance of angiogenesis, Ki-67, p53 and p21 expression - a population-based endometrial carcinoma study. (ekstern lenke)
• Salvesen, Helga; Akslen, Lars A. (1999). Strong prognostic influence of reduced p16 protein expression in endometrial carcinomas. A large population based study. (Abstract no. 0-079). (ekstern lenke)
• Geisler, Stephanie; Lønning, Per Eystein; Aas, T et al. (1999). Influence of TP53 gene alterations and Her-2 expression on the respons to treatment with doxorubicin in locally advanced breast cancer. (Abs. no. 227). (ekstern lenke)
• Straume, Oddbjørn; Akslen, Lars A. (1999). Loss of nuclear expression of p16 protein correlates with increased tumor cell proliferation and poor patient outcome in patients with vertical growth phase melanoma. (Abstract no. P-487). (ekstern lenke)
• Heuch, Jane M.; Heuch, Ivar; Akslen, Lars A. et al. (1998). Risk of primary childhood brain tumors related to birth characteristics: a Norwegian prospective study. (ekstern lenke)
• Salvesen, Helga; Iversen, Ole-Erik; Akslen, Lars A. (1998). Independent prognostic importance of microvessel density in endometrial carcinoma. (ekstern lenke)
• Frich, L; Akslen, Lars A.; Glattre, E (1998). Økt forekomst av kreft i skjoldkjertelen blant norske kvinner gift med fiskere. (ekstern lenke)
• Salvesen, Helga; Iversen, Ole-Erik; Akslen, Lars A. (1998). Prognostic impact of morphometric nuclear grade of endometrial carcinoma. (ekstern lenke)
• Akslen, Lars A.; Monstad, SE; Larsen, B et al. (1998). Frequent mutations of the p53 gene in cutaneous melanoma of the nodular type. (ekstern lenke)
• Salvesen, Helga; Akslen, Lars A.; Albrektsen, Grethe et al. (1998). Poorer survival of nulliparous women with endometrial carcinoma. (ekstern lenke)
• Akslen, Lars A.; Sothern, RB (1998). Seasonal variations in the presentation and growth of thyroid cancer. (ekstern lenke)
• Salvesen, Helga; Iversen, Ole-Erik; Akslen, Lars A. (1998). Independent prognostic importance of microvessel density in endometrial carcinoma. (ekstern lenke)
• Heuch, Jane M.; Heuch, Ivar; Akslen, Lars A. et al. (1998). Risk of primary childhood brain tumors related to birth characteristics: a Norwegian prospective study. (ekstern lenke)
• Heuch, Jane M.; Heuch, Ivar; Akslen, Lars A. et al. (1998). Risk of primary childhood brain tumors related to birth characteristics: a Norwegian prospective study. (ekstern lenke)
• Akslen, Lars A.; Monstad, S. E.; Larsen, B. et al. (1998). Frequent mutations of the p53 gene in cutaneous melanoma of the nodular type. (ekstern lenke)
• Salvesen, Helga; Akslen, Lars A.; Albrektsen, Grethe et al. (1998). Decreased survival for nulliparous women with endometrial carcinoma. Is the relationship due to biology or behaviour?. (ekstern lenke)
• Salvesen, Helga; Iversen, Ole-Erik; Akslen, Lars A. (1998). Identification of high-risk patients by assessment of nuclear Ki67 expression in a prosepective study of endometrial carcinoma patients. (ekstern lenke)
• Salvesen, Helga; Iversen, Ole-Erik; Akslen, Lars A. (1998). Prognostic impact of morphometric nuclear grade in endometrial carcinoma. (ekstern lenke)
• Haugen, Dagny R. Faksvåg; Varhaug, Jan Erik; Akslen, Lars A. et al. (1998). Diagnostisk molekylærbiologi ved solide svulster - thyreoidea. (ekstern lenke)
• Faksvåg Haugen, D.R.; Varhaug, J.E.; Akslen, Lars A. et al. (1998). Diagnostisk molekylærbiologi ved solide svulster: Thyreoideacancer. (ekstern lenke)
• Heuch, Jane M.; Heuch, Ivar; Akslen, Lars A. et al. (1998). Risk of primary childhood brain tumors related to birth characteristics: a Norwegian prospective study. (ekstern lenke)
• Salvesen, Helga; Iversen, Ole-Erik; Akslen, Lars A. (1998). Identification of high-risk patients by assessment of nuclear Ki-67 expression in a prospective study of endometrial carcinomas. (ekstern lenke)
• Salvesen, Helga; Akslen, Lars A.; Iversen, Torbjørn et al. (1997). Recurrent endometrial carcinoma and the value of routine follow-up. (ekstern lenke)
• Straume, O; Akslen, Lars A. (1997). Alterations and prognostic significance of p16 and p53 protein expression in subgroups of cutaneous melanoma. (ekstern lenke)
• Salvesen, Helga; Iversen, Ole-Erik; Akslen, Lars A. (1997). Prognostisk betydning av tumorbiologiske markører ved kreft i livmorslimhinnen. (ekstern lenke)
• Halvorsen, Ole Johan; Haukaas, Svein Andreas; Høstmark, Jens et al. (1997). Expression of p16 protein in prostatic adenocarcinomas, intraepithelial neoplasia and benign/hyperplastic glands. (ekstern lenke)
• Salvesen, Helga; Akslen, Lars A. (1997). Recurrence of endometrial carcinoma and the value of routine follow up. (ekstern lenke)
• Ellis, PA; Lønning, Per Eystein; Børresen-Dale, Anne-Lise et al. (1997). Absence of p21 expression is associated with abnormal p53 in human breast carcinomas. (ekstern lenke)
• Salvesen, Helga; Akslen, Lars A.; Iversen, Torbjørn et al. (1997). Recurrence of endometrial carcinoma and the value of routine follow up. (ekstern lenke)
• Frich, L; Akslen, Lars A.; Glattre, E (1997). Increased risk of thyroid cancer among Norwegian females married to fishery workers. (ekstern lenke)
• Ellis, PA; Lønning, Per Eystein; Aas, Turid et al. (1997). Absence of p21 expression is associated with abnormal p53 in human breast carcinomas. (ekstern lenke)
• Ellis, PA; Lønning, Per Eystein; Aas, Turid et al. (1997). Absence of p21 Expression is associated with abnormal p53 in human breast carcinomas. (ekstern lenke)
• Paulsen, Trond H; Aas, Turid; Børresen, A-L et al. (1997). Angiogenesis does not predict clinical response to doxorubicin monotherapy in patients with locally advanced breast cancer. (ekstern lenke)
• Paulsen, Trond H; Aas, Turid; Børresen, Anne-Lise et al. (1997). Angiogenesis does not predict clinical response to doxorubicin monotherapy in patients with locally advanced breast cancer. (ekstern lenke)
• Aas, Turid; Geisler, Stephanie; Paulsen, Trond H et al. (1996). Primary systemic treatment with weekly doxorubicin monotherapy in women with locally advanced breast cancer; clinical experience and parameters predicting outcome. (ekstern lenke)
• Akslen, Lars A.; Mæhle, B.O.; Varhaug, Jan Erik (1996). Aggressive thyroid carcinoma with predominant cribriform growth pattern. (ekstern lenke)
• Aas, Turid; Geisler, Stephanie; Paulsen, Trond H et al. (1996). Primary systemic treatment with weekly doxorubicin monotherapy in women with locally advanced breast cancer; Clinical experience and parameters predicting outcome. (ekstern lenke)
• Akslen, Lars A. (1996). Thyroid carcinomas with tall-cell and columnar-cell features (letter). (ekstern lenke)
• Akslen, Lars A. (1996). Incidence of thyroid cancer in New Caledonia, South Pacific, during 1985-1992 (letter). (ekstern lenke)
• Aas, T; Børresen, A-L; Geisler, D et al. (1996). Spesific TP53 gene mutations are associated with de novo resistance to doxorubicin in breast cancer patients. (ekstern lenke)
• Straume, O; Akslen, Lars A. (1996). Independent prognostic importance of vascular invasion in nodular melanomas. (ekstern lenke)
• Haugen, Dagny R. Faksvåg; Akslen, Lars A.; Varhaug, Jan Erik et al. (1996). Expression of c-erbB-3 and c-erbB-4 proteins in papillary thyroid carcinomas. (ekstern lenke)
• Aas, T; Børresen, A-L; Geisler, Stephanie et al. (1996). Relationship between mutations in the TP53 gene and De Novo resistance and early relapse following treatment with doxorubicin in patients with breast cancer. (ekstern lenke)
• Ness, GO; Haugen, Dagny F. Faksvåg; Varhaug, Jan Erik et al. (1996). Cytoplasmatic localization of EGF receptor in papillary thyroid carcinomas: Association with the 150-kDa receptor forms. (ekstern lenke)
• Ness, G. O.; Bjerkvig, Rolf; Akslen, Lars A. et al. (1996). Primary organ-culture of non neoplastic and neoplastic thyroid tissue as multicellular spheroids. (ekstern lenke)
• Aas, Turid; Børresen, Anne-Lise; Geisler, Stephanie et al. (1996). Specific p53 mutations are associated with de novo resistance to doxorubicin in breast cancer patients. (ekstern lenke)
• Ness, GO; Bjerkvig, Rolf; Akslen, Lars A. et al. (1995). Primary organ culture of non-neoplastic and neoplastic thyroid tissue multicellular spheroids. (ekstern lenke)
• Høstmark, J; Aas, T; Akslen, Lars A. et al. (1995). Lack of diagnostic value of DNA content and p53 immunostaining in normal, hyperplastic and neoplastic parathyroid tissue. (ekstern lenke)
• Akslen, Lars A. (1995). Histopatologiens betydning for vurdering av kreftforekomst og kreftårsaker. (ekstern lenke)
• Akslen, Lars A.; Varhaug, Jan Erik (1995). Oncoproteins and tumor progression in papillary thyroid carcinoma. Presence of epidermal growth factor receptor (EGF-R), c-erbB-2 protein, estrogen receptor related protein (p29), p21-ras protein and proliferation indicators in relation to tumor recurrences and patients survival. (ekstern lenke)
• Akslen, Lars A.; Varhaug, Jan Erik (1995). Oncoproteins and tumor progression in papillary thyroid carcinoma. Presence of epidermal growth factor receptor (EGF-R), c-erbB-2 protein, estrogen receptor related protein (29), p21-ras protein and proliferation indicators in relation to tumor recurrences and patient survival. (ekstern lenke)
• Ness, GO; Bjerkvig, Rolf; Akslen, Lars A. et al. (1995). Primary organ culture of non-neoplastic and neoplastic thyroid tissue as multicellular spheroids. (ekstern lenke)
• Ness, GO; Bjerkvig, Rolf; Akslen, Lars A. et al. (1995). Primary organ culture of non-neoplastic and neoplastic thyroid tissue as multicellular spheroids. (ekstern lenke)
• Akslen, Lars A.; Varhaug, Jan Erik; Aas, T et al. (1994). Increase of endo- and exo-peptidases in thyroid tumors. (ekstern lenke)
• Akslen, Lars A. (1994). Thyroid cancer: some aspects of epidemiology and etiological factors, pathological features and tumour biology. (ekstern lenke)
• Akslen, Lars A.; Varhaug, Jan Erik; Aas, T et al. (1994). Increase of endo- and exo-peptidases in thyroid tumours. (ekstern lenke)
• Kitinya, JN; Mbonde, MP; Guthe, HJ et al. (1994). Ploidy and proliferative rates in carcinomas of the breast in Tanzania. (ekstern lenke)
• Akslen, Lars A.; Varhaug, Jan Erik; Aas, T et al. (1994). Increase of endo-and exo-peptidases in thyroid tumors. (ekstern lenke)
• Akslen, Lars A. (1994). Kreft i skjoldbruskkjertelen - økning i yngre årskull. (ekstern lenke)
• Kitinya, JN; Mbonde, MP; Guther, HJ et al. (1994). Ploidy and proliferative rates in carcinomas of the breast in Tanzania. (ekstern lenke)
• Akslen, Lars A. (1994). Etiologiske og patobiologiske aspekter ved malignt melanom. (ekstern lenke)
• Akslen, Lars A. (1993). Prognostic importance of histologic grading in papillary thyroid carcinoma. (ekstern lenke)
• Haugen, Dagny R. Faksvåg; Akslen, Lars A.; Varhaug, Jan Erik et al. (1993). Demonstration of a TGF-_a-EGF receptor autocrine loop and c-myc protein overexpression in papillary thyroid carcinomas. (ekstern lenke)
• Akslen, Lars A.; Myking, Andreas O; Salvesen, Helga et al. (1993). Prognostic impact of EGF-receptor in papillary thyroid carcinoma. (ekstern lenke)
• Thoresen, Steinar Østerbø; Akslen, Lars A.; Glattre, E. et al. (1993). Thyroid cancer in children in Norway 1953-1987. (ekstern lenke)
• Akslen, Lars A.; Haldorsen, T.; Thoresen, Steinar Østerbø et al. (1993). Incidence pattern of thyroid cancer in Norway: influence of birth cohort and time period. (ekstern lenke)
• Akslen, Lars A.; Myking, Andreas O; Salvesen, Helga et al. (1993). Prognostic importance of various clinicopathological features in papillary thyroid carcinoma. (ekstern lenke)
• Akslen, Lars A.; Myking, Andreas O; Salvesen, Helga et al. (1993). Prognostic impact of EGF-receptor in papillary thyroid carcinoma. (ekstern lenke)
• Akslen, Lars A.; Myking, Andreas O; Salvesen, Helga et al. (1993). Prognostic importance of various clinicopathological features in papillary thyroid carcinoma. (ekstern lenke)
• Salvesen, Helga; Njølstad, Pål Rasmus; Akslen, Lars A. et al. (1992). Disease free and cause specific survival in patients with papillary thyroid carcinoma. A multifactorial analysis. (ekstern lenke)
• Salvesen, Helga; Njølstad, Pål Rasmus; Akslen, Lars A. et al. (1992). Thyroid carcinoma. Results from surgical treatment in 211 consecutive patients. (ekstern lenke)
• Haugen, Dagny R. Faksvåg; Akslen, Lars A.; Varhaug, Jan Erik et al. (1992). Expression of c-erbB-2 protein in papillary thyroid carcinomas. (ekstern lenke)
• Akslen, Lars A.; Glattre, E. (1992). Second malignancies in thyroid cancer patients: a population-based survey of 3658 cases from Norway. (ekstern lenke)
• Akslen, Lars A.; Myking, Andreas O (1992). Differentiated thyroid carcinomas: the relevance of various pathological features for tumour classification and prediction of tumour progress. (ekstern lenke)
• Akslen, Lars A.; Nilssen, S.; Kvåle, Gunnar (1992). Reproductive factors and risk of thyroid cancer. A prospective study of 63090 women from Norway. (ekstern lenke)
• Akslen, Lars A.; Mørkve, Odd (1992). Expression of p53 protein in cutaneous melanoma. (ekstern lenke)
• Småland, Rune; Akslen, Lars A.; Tønder, Bjarne et al. (1991). Radical radiation treatment of invasive and locally advanced bladder carcinoma in elderly patients. (ekstern lenke)
• Salvesen, Helga; Njølstad, Pål Rasmus; Akslen, Lars A. et al. (1991). Thyroid carcinoma: Results from surgical treatment in 211consecutive patients. (ekstern lenke)
• Akslen, Lars A.; Haldorsen, T.; Thoresen, Steinar Østerbø et al. (1991). Survival and cause of death in thyroid cancer: A population-based study of 2479 cases from Norway. (ekstern lenke)
• Salvesen, Helga; Njølstad, Pål Rasmus; Akslen, Lars A. et al. (1991). Thyroid carcinoma. Results from a uniform surgical strategy 1971-1985. (ekstern lenke)
• Dæhlin, L.; Akslen, Lars A.; Haukaas, Svein Andreas (1991). Squamous cell carcinoma of the urinary bladder. (ekstern lenke)
• Akslen, Lars A.; Karwinski, Barbara; Maartmann-Moe, H. et al. (1991). Periodicity in metastatic tumour growth demonstrated in human liver at autopsy. (ekstern lenke)
• Glattre, E.; Høstmark, A.; Thoresen, Steinar Østerbø et al. (1990). Provocation of thyroid neoplasms in female Wistar rats fed n-3 or n-6 fatty acids in the feed. (ekstern lenke)
• Akslen, Lars A.; Myking, Andreas O; Mørkve, Odd et al. (1990). Increased content of chronium and nickel in lung tissues patients with bronchial carcinoma. (ekstern lenke)
• Rotevatn, Svein; Akslen, Lars A.; Bjerke, Elisabeth (1989). Lifestyle and mortality among Norwegian men. (ekstern lenke)
• Akslen, Lars A.; Andersen, Knut-Jan; Bjerkvig, Rolf (1988). Characteristics of Human and Rat Glioma Cells Grown in a Defined Medium. (ekstern lenke)
• Rotevatn, S.; Akslen, Lars A.; Bjelke, Erik (1988). Life-style and caridovascular mortality among Norwegian men (Abstract). (ekstern lenke)
• Akslen, Lars Andreas; Hove, Leiv M (1987). Malignt melanom - amelanotisk type. (ekstern lenke)
• Hove, Leiv M; Akslen, Lars Andreas (1987). Malignt melanom i hud. (ekstern lenke)
• Akslen, Lars Andreas; Hove, Leiv M; Hartveit, Flora (1987). Metastatic distribution in malignant melanoma. A 30-year autopsy study.. (ekstern lenke)
• Hove, Leiv M; Akslen, Lars Andreas; Hartveit, Flora (1987). Malignant melanoma of the skin. Changing clinical stage at presentation 1955-79. (ekstern lenke)

Errata

• Lien, Hilde Eide; Berg, Hege Fredriksen; Halle, Mari Kyllesø et al. (2023). Corrigendum to “Single-cell profiling of low-stage endometrial cancers identifies low epithelial vimentin expression as a marker of recurrent disease” [EBioMedicine 92 (2023) 104595] (eBioMedicine (2023) 92, (S2352396423001603), (10.1016/j.ebiom.2023.104595)). (ekstern lenke)
• Duffy, David L.; Zhu, Gu; Li, Xin et al. (2019). Erratum to: Novel pleiotropic risk loci for melanoma and nevus density implicate multiple biological pathways (Nature Communications, (2018), 9, 1, (4774), 10.1038/s41467-018-06649-5). (ekstern lenke)

Oppslagsverk

• Akslen, Lars Andreas; Alfsen, G. Cecilie; Chen, Ying (2023). Faget og foreningen gjennom 100 år. Den Norske Patologforening 1923-2023. . (ekstern lenke)

Vitenskapelig foredrag

• Thomsen, Liv Cecilie Vestrheim; Honore, Alfred; Reisæter, Lars Anders Rokne et al. (2023). Survival and biomarkers in a prospective non-randomized phase I trial of dendritic cell-based cryoimmunotherapy combined with checkpoint inhibitors in metastatic castration-resistant prostate cancer (mCRPC) . (ekstern lenke)
• Valla, Marit; Vatten, Lars Johan; Engstrøm, Monica J et al. (2016). Molecular subtypes of breast cancer: long-term incidence trends and prognostic differences. (ekstern lenke)
• Valla, Marit; Engstrøm, Monica J; Ytterhus, Borgny et al. (2016). FGD5 amplification in breast cancer patients is associated with tumour proliferation and a poorer prognosis. (ekstern lenke)
• Engstrøm, Monica J; Opdahl, Signe; Hagen, Anne Irene et al. (2013). Molekylære subtyper og overlevelse ved brystkreft. (ekstern lenke)
• Engstrøm, Monica J; Opdahl, Signe; Hansen, Åse Kristin Skain et al. (2013). Molekylære subtyper og overlevelse ved brystkreft. (ekstern lenke)
• Biermann, Martin; Johnsen, Boel; Naum, Alexandru Gratian et al. (2012). Multimodal imaging for suspected recurrent differentiated thyroid cancer (DTC): FDG-PET-CT, I-131-SPECT-CT, ultrasound (US) and US-guided fine needle biopsy (FNB). (ekstern lenke)
• Biermann, Martin; Johnsen, Boel; Naum, Alexandru Gratian et al. (2011). Multimodal imaging for diagnosis and treatment of recurrent differentiated thyroid cancer (DTC)FDG-PET-CT, contrast-enhanced CT (CE-CT), I-131-SPECT-CT, ultrasound (US) and US-guided fine needle biopsy (FNB). (ekstern lenke)
• Moestue, Siver Andreas; Huuse, Else Marie; Lindholm, Evita Maria et al. (2011). DCE-MRI for early therapy monitoring of anti-angiogenic therapy. (ekstern lenke)
• Huuse, Else Marie; Moestue, Siver Andreas; Bathen, Tone Frost et al. (2011). In vivo Dynamic Contrast Enhanced MRI & Histopathological Assessment of Tumor Angiogenesis in Luminal-like and Basal-like Breast Cancer Xenografts. (ekstern lenke)
• Biermann, Martin; Johnsen, Boel; Naum, Alexandru Gratian et al. (2011). FDG-PET-CT, I-131-SPECT-CT, ultrasound (US) and US-guided fine needle biopsy (FNB) for recurrent differentiated thyroid cancer (DTC). (ekstern lenke)
• Moestue, Siver Andreas; Huuse, Else Marie; Lindholm, Evita Maria et al. (2011). Early vascular response to bevacizumab treatment measured by DCE-MRI in breast cancer xenografts. (ekstern lenke)
• Nygård, Yngve; Halvorsen, Ole Johan; Gravdal, Karsten et al. (2010). Preliminære resultater av PCA3 måling i urin hos pasienter med cancer prostatae. (ekstern lenke)
• Nygård, Yngve; Waage, Jo Erling Riise; Halvorsen, Ole Johan et al. (2010). Real time elastografi ved cancer prostatae. (ekstern lenke)
• Biermann, Martin; Johnsen, Boel; Naum, Alexandru Gratian et al. (2010). Multimodal imaging of differentiated thyroid cancer: FDG-PET-CT, I-131-SPECT-CT and ultrasound. (ekstern lenke)
• Reisæter, Lars Anders; Wold, Tor; Haukaas, Svein Andreas et al. (2010). Er MR-prostata nyttig for å avklare videre oppfølgningsbehov hos pasienter med 2 eller flere negative biopsiserier?. (ekstern lenke)
• Reisæter, Lars Anders; Nygård, Yngve; Halvorsen, Ole Johan et al. (2010). Er preoperativ MR-prostata nyttig for å avklare korrekt T-stadium forut for kirurgi?. (ekstern lenke)
• Huuse, Else Marie; Moestue, Siver Andreas; Lindholm, Evita et al. (2010). In vivo magnetic resonance imaging and histopathological assessment of tumor microenvironment in luminal-like and basal-like breast cancer xenografts. (ekstern lenke)
• Ke, Xisong; Li, Wencheng; Qu, Yi et al. (2009). EMT Promotes Malignant Transformation of Prostate Epithelial Cells in Culture. (ekstern lenke)
• Ke, Xisong; Qu, Yi; Rostad, Kari et al. (2009). Genome-wide profiling of histone H3 lysine 4 and lysine 27 trimethylation reveals an epigenetic signature in prostate carcinogenesis. (ekstern lenke)
• Ke, Xisong; Qu, Yi; Rostad, Kari et al. (2008). Epithelial to mesenchymal transition of a primary, immortalized prostate cell line is associated with gene expression switches of entire cell attachment modules. (ekstern lenke)
• Ke, Xisong; Qu, Yi; Rostad, Kari et al. (2008). Polycomb group target genes and bivalent H3K4 & K27me3 modifications in human embryonic cells were enriched among dysregulated genes in prostate cancer. (ekstern lenke)
• Ke, Xisong; Øyan, Anne Margrete; Rostad, Kari et al. (2007). Functional oncogenomics and epigenomics analysis of prostate cancer. (ekstern lenke)
• Rostad, Kari; Schlomm, Thorsten; Haukaas, Svein Andreas et al. (2007). Detection of TMPRSS2:ERG translocations in the urine of prostate cancer patients and identification of ERG target genes. (ekstern lenke)
• Rostad, Kari; Mannelqvist, Monica; Halvorsen, Ole Johan et al. (2006). ERG upregulation and related transcription factors in prostate cancer. (ekstern lenke)
• Kalland, Karl-Henning; Rostad, Kari; Mannelqvist, Monica et al. (2006). Global gene expression analysis of transcription factors in prostate cancer and cell lines. (ekstern lenke)
• Kalland, Karl-Henning; Halvorsen, Ole Johan; Øyan, Anne Margrete et al. (2004). Gene expression profiling in prostate cancer refined by pairwise comparisons of cDNA microarrays from benign and malignant tissue. (ekstern lenke)
• Halvorsen, Ole Johan; Rostad, Kari; Øyan, Anne Margrete et al. (2004). Gene expression profiles in prostate cancer: identification of upregulated SIM2 gene validated in archival tissue, relation to histological grading and prognosis. (ekstern lenke)
• Kalland, Karl-Henning; Øyan, Anne Margrete; Akslen, Lars A. et al. (2003). Global analysis of gene expression and regulatory patterns in cancer. (ekstern lenke)
• Halvorsen, Ole J.; Øyan, A M; Bø, TH et al. (2003). Gene expression profiling in prostate cancer: Cluster analysis and association with tumor differentiation. (ekstern lenke)
• Kalland, Karl-Henning; Halvorsen, Ole J.; Øyan, Anne Margrete et al. (2003). Global analysis of gene expression and regulatory patterns in urogenital tumours using DNA microarrays. (ekstern lenke)
• Kalland, Karl-Henning; Akslen, Lars A.; Halvorsen, Ole J. et al. (2003). DNA microarray studies of human cancer - pitfalls and outlook. (ekstern lenke)
• Halvorsen, Ole Johan; Øyan, Anne Margrete; Hellem Bø, Trond et al. (2003). Gene expression profiling in prostate cancer: cluster analysis and association with tumor differentation. (ekstern lenke)
• Halvorsen, Ole J.; Øyan, Anne Margrete; Bø, Trond Hellem et al. (2003). Gene expression profiling in prostate cancer. (ekstern lenke)
• Olsen, Sue; Bø, Trond Hellem; Rostad, Kari et al. (2003). Comparison of DNA microarray and real time quantitative PCR for quantitation of gene expression of selected genes in prostate cancer. (ekstern lenke)
• Molven, Anders; Immervold, H; Kugarajh, K et al. (2003). Mutation analysis of the RAS-RAF pathway in pancreatic adenocarcinomas and malignant melanomas. (ekstern lenke)
• Opsahl, EM; Aas, Turid; Paulsen, Trond Harder et al. (2002). Cancer mammae behandlet med brystbevarende kirurgi ved Haukeland sykehus 1984-1995. (ekstern lenke)
• Halvorsen, Ole J.; Haukaas, Sven; Høisæter, Per Åge et al. (2001). Prognostisk betydning av angiogenese (microvessel density - MVD) og proliferasjonsmarkøren Ki-67 ved lokalisert prostatacencer. (ekstern lenke)
• Halvorsen, OJ; Haukaas, Svein Andreas; Høisæter, PÅ et al. (1999). Prognostic importance of microvessel density (MVD) in clinically localized prostate cancer. (ekstern lenke)
• Hove, LM; Akslen, Lars A. (1998). Malignt melanom på hender. (ekstern lenke)
• Hove, LM; Akslen, Lars A. (1998). Malignant melanoma of the hand. A 25-year clinico-pathological study. (ekstern lenke)
• Halvorsen, OJ; Haukaas, Svein Andreas; Høisæter, PÅ et al. (1998). Prognostic importance of microvessel density (MVD) in clinically localized prostate cancer. (ekstern lenke)
• Varhaug, Jan Erik; Boman, Helge; Akslen, Lars A. (1998). Profylaktisk thyroidectomi hos barn - initial erfaring. (ekstern lenke)
• Salvesen, Helga; Iversen, Ole-Erik; Akslen, Lars A. (1997). Independent prognostic importance of microvessel density in endometrial carcinoma. [poster]. (ekstern lenke)
• Rotevatn, S.; Akslen, Lars A.; Bjelke, Erik (1989). Mortality form ischemic heart disease related to life-style differences among Norwegian men (Abstract). (ekstern lenke)

Short communication

• Thomsen, Liv Cecilie Vestrheim; Honore, Alfred; Gjertsen, Bjørn Tore et al. (2023). A prospective non-randomized phase I trial of dendritic cell–based cryoimmunotherapy combined with checkpoint inhibitors in mCRPC.. (ekstern lenke)
• Straume, Oddbjørn; Akslen, Lars A. (2004). Lymphatic vessel density and prognosis in cutaneous melanoma. (ekstern lenke)

Poster

• Thomsen, Liv Cecilie Vestrheim; Honore, Alfred; Reisæter, Lars Anders Rokne et al. (2023). Survival and biomarkers in a prospective non-randomized phase I trial of dendritic cell-based cryoimmunotherapy combined with checkpoint inhibitors in metastatic castration-resistant prostate cancer (mCRPC). (ekstern lenke)
• Kraby, Maria Ryssdal; Krüger, Kristi; Opdahl, Signe et al. (2016). Microvascular proliferation in breast cancer. (ekstern lenke)
• Valla, Marit; Vatten, Lars Johan; Engstrøm, Monica J et al. (2016). Molecular subtypes of breast cancer: Long term incidence trends and prognostic differences. (ekstern lenke)
• Ramnefjell, Maria; Aamelfot, Christina; Helgeland, Lars et al. (2016). Microvascular proliferation is Associated With Aggressive Tumor Features and Reduced Survival in Lung Adenocarcinomas. (ekstern lenke)
• Ramnefjell, Maria; Aamelfot, Christina; Helgeland, Lars et al. (2016). Low Expression of SerpinB2 is Associated With Reduced Survival in Lung Adenocarcinomas. (ekstern lenke)
• Kraby, Maria Ryssdal; Opdahl, Signe; Krüger, Kristi et al. (2014). Microvascular proliferation in breast cancer. (ekstern lenke)
• Engstrøm, Monica J; Opdahl, Signe; Romundstad, Pål Richard et al. (2014). Molecular subtypes, histopathological grade and survival in a historic cohort of breast cancer patients. (ekstern lenke)
• Moestue, Siver Andreas; Flatabø, Silje; Huuse, Else Marie et al. (2012). Metabolic responses to VEGF inhibition in patient-derived breast cancer xenografts. (ekstern lenke)
• Biermann, Martin; Reitan, Bernt Christian; Johnsen, Boel et al. (2012). False positive FDG-uptake in neck and mediastinum in recurrent differentiated thyroid cancer (DTC). (ekstern lenke)
• Biermann, Martin; Johnsen, Boel; Naum, Alexandru Gratian et al. (2010). Multimodal imaging for recurrent differentiated thyroid cancer: Ultrasound, I-131-SPECT-CT, FDG-PET-CT and fine-needle biopsy. (ekstern lenke)
• Straume, Oddbjørn; Shimamura, Takeshi; Øyan, Anne Margrete et al. (2009). Suppression of heat shock Protein 27 induces long-term dormancy in human breast cancer. (ekstern lenke)
• Ke, Xisong; Qu, Yi; Rostad, Kari et al. (2009). Genome-wide profiling of histone H3 lysine 4 and lysine 27 trimethylation reveals an epigenetic signature in prostate carcinogenesis. (ekstern lenke)
• Moen, Ingrid; Øyan, Anne Margrete; Kalland, Karl-Henning et al. (2009). Hyperoxic Treatment induces Mesenchymal-to-Epithelial Transition in a Rat Adenocarcinoma Model. (ekstern lenke)
• Ke, Xisong; Li, Wencheng; Qu, Yi et al. (2009). Stepwise prostate carcinogenesis in vitro culture. (ekstern lenke)
• Trovik, Jone; Wik, Elisabeth; Stefansson, Ingunn Marie et al. (2009). Stathmin is superior to AKT and Phospho-AKT staining to detect PI3Kinase activation and aggressive endometrial cancer. (ekstern lenke)
• Ke, Xisong; Qu, Yi; Rostad, Kari et al. (2009). Genome-wide profiling of histone H3 lysine 4 and lysine 27 trimethylation reveals an epigenetic signature in prostate carcinogenesis. (ekstern lenke)
• Ke, Xisong; Qu, Yi; Goldfinger, Naomi et al. (2009). A novel model of stepwise prostate carcinogenesis in culture. (ekstern lenke)
• Ke, Xisong; Qu, Yi; Goldfinger, Naomi et al. (2009). Epithelial to mesenchymal transition of a primary prostate cell line before malignant transformation with switches of cell adhesion modules. (ekstern lenke)
• Ke, Xisong; Qu, Yi; Halvorsen, Ole Johan et al. (2008). Polycomb (PcG) targets are enriched in repressed genes in prostate cancer. (ekstern lenke)
• Mannelqvist, Monica; Bø, Trond Hellem; Bredholt, Geir et al. (2007). Patterns of gene expression related to vascular invasion and aggressive features in endometrial cancer. (ekstern lenke)
• Mannelqvist, Monica; Bø, Trond Hellem; Bredholt, Geir et al. (2007). Patterns of gene expression related to vascular invasion and aggressive features in endometrial cancer. (ekstern lenke)
• Rostad, Kari; Schlomm, Thorsten; Haukaas, Svein Andreas et al. (2007). Detection of TMPRSS2:ERG translocations in the urine of prostate cancer patients. (ekstern lenke)
• Halvorsen, Ole Johan; Rostad, Kari; Øyan, Anne Margrete et al. (2006). Single-minded 2 homolog (SIM2) is overexpressed in prostate cancer. (ekstern lenke)
• Rostad, Kari; Mannelqvist, Monica; Halvorsen, Ole Johan et al. (2006). ERG upregulation in relation to other transcription factors in prostate cancer. (ekstern lenke)
• Salvesen, Helga; Bø, Trond Hellem; Stefansson, Ingunn Marie et al. (2006). Gene expression profiles identify an aggressive phenotype in endometrial carcinoma. (ekstern lenke)
• Kalland, Karl-Henning; Halvorsen, Ole Johan; Rostad, Kari et al. (2005). Very high expression of specific transcription factors in prostate cancer compared with paired benign prostate tissue. (ekstern lenke)
• Kalland, Karl-Henning; Halvorsen, Ole Johan; Mannelqvist, Monica et al. (2005). ETS transcription factors in prostate cancer. (ekstern lenke)
• Halvorsen, Ole Johan; Rostad, Kari; Øyan, Anne Margrete et al. (2005). Single-minded 2 homolog gene (SIM2) is overexpressed in prostate cancer. (ekstern lenke)
• Kalland, Karl-Henning; Halvorsen, Ole J.; Øyan, Anne Margrete et al. (2003). Gene expression profiling in prostate cancer refined by pairwise comparisons of cDNA microarrays from benign and malignant tissue. (ekstern lenke)
• Haukaas, Sven; Halvorsen, Ole J.; Dæhlin, Lars et al. (2003). Preoperative PSA may not be a predictor of clinical recurrence after radical prostatectomy. (ekstern lenke)
• Halvorsen, Ole J.; Haukaas, Sven; Akslen, Lars A. (2002). Expression of PTEN/P27 proteins in prostate cancer using a tissue microarray setup predicts progression after radical prostatectomy. (ekstern lenke)
• Salvesen, Helga; Akslen, Lars A.; Albrektsen, Grethe et al. (1997). Decreased survival for nulliparous women with endometrial carcinoma. Is the relationship dur to biology or behaviour? [poster]. (ekstern lenke)
• Monsen, Rosmari; Jøsok, Randi; Akslen, Lars A. et al. (1986). Secretion of Lysosomal Glycosidases from Human and Rat Brain Tumour Cell Lines. (ekstern lenke)
• Akslen, Lars A.; Bjerkvig, Rolf; Andersen, Knut-Jan et al. (1986). Glioma Cells Cultured Under Serum Free Conditions. (ekstern lenke)

Vitenskapelig Kapittel/Artikkel/Konferanseartikkel

• Milosevic, Vladan; Edelmann, Reidunn Jetne; Fosse, Johanna Hol et al. (2022). Molecular Phenotypes of Endothelial Cells in Malignant Tumors. (ekstern lenke)
• Blanchard, Anne; Wik, Elisabeth; Akslen, Lars Andreas (2022). HER2 Revisited: Reflections on the Future of Cancer Biomarker Research. (ekstern lenke)
• Vethe, Heidrun; Bjørnstad, Ole Vidhammer; Carrasco Fernandez, Manuel et al. (2022). Neurogenesis in the Tumor Microenvironment. (ekstern lenke)
• Ramnefjell, Maria Paula; Akslen, Lars Andreas (2022). Tumor-Vascular Interactions in Non-Small Cell Lung Cancer. (ekstern lenke)
• Akslen, Lars A. (2017). Tissue-Based Biomarkers of Tumor-Vascular Interactions. (ekstern lenke)
• Wik, Elisabeth; Akslen, Lars A. (2017). Gene expression signatures of the tumor microenvironment: relation to tumor progress in breast cancer. (ekstern lenke)
• Akslen, Lars A. (2008). Pathology of Breast Tumors in Hereditary Breast Cancer. (ekstern lenke)

Vitenskapelig antologi/Konferanseserie

• Akslen, Lars Andreas; Watnick, Randolph S. (2022). Biomarkers of the Tumor Microenvironment. (ekstern lenke)
• Akslen, Lars A.; Watnick, Randolph S. (2017). Biomarkers of the Tumor Microenvironment: Basic Studies and Practical Applications. (ekstern lenke)

Faglig kapittel

• Akslen, Lars Andreas (2022). Tissue-Based Biomarkers of Tumor-Vascular Interactions. (ekstern lenke)
• Wik, Elisabeth; Ingebriktsen, Lise Martine; Akslen, Lars Andreas (2022). Gene Expression Signatures of the Tumor Micoenvironment: Relation to Tumor Phenotypes and Progress in Breast Cancer . (ekstern lenke)

Doktorgradsavhandling

• Klingen, Tor Audun; Akslen, Lars A. (2018). Vascular invasion by tumor cells, and other prognostic factors in a population-based breast cancer study. (ekstern lenke)
• Ramnefjell, Maria; Akslen, Lars A.; Helgeland, Lars (2018). Prognostic biomarkers and clinico-pathologic characteristics in non-small cell lung cancer. A study with special focus on tumor-vascular interactions. (ekstern lenke)
• Hugdahl, Emilia ; Akslen, Lars A. (2018). Prognostic and molecular markers in primary and metastatic cutaneous melanoma. (ekstern lenke)
• Aziz, Sura Mohammed; Akslen, Lars A. (2017). Biological and clinico-pathologic markers in breast cancer. With focus on histologic features, markers of proliferation and angiogenesis. (ekstern lenke)
• Krüger, Kristi; Akslen, Lars A. (2017). Markers of angiogenesis and the basal-like phenotype of breast cancer. (ekstern lenke)
• Knutsvik, Gøril; Akslen, Lars A. (2016). Biomarkers in breast cancer, with special focus on tumor cell proliferation. (ekstern lenke)
• Ahmed, Lavina; Akslen, Lars A. (2016). Axl as a Biomarker in Breast and Lung Cancer. (ekstern lenke)
• Akslen, Lars A. (1993). Thyroid cancer. A study of incidence pattern, pathological features and prognosis. (ekstern lenke)

Mastergradsoppgave

• Litlabø, Hanne Bjelland; Finne, Kenneth; Akslen, Lars A. (2018). Effects of Breast Cancer Cell Secretomes on Mammary Fibroblast Phenotype. (ekstern lenke)

Kronikk

• Strand, Roger; Akslen, Lars A. (2017). Hva er ansvarlig kreftforskning?. (ekstern lenke)
• Paulsen, Trond H; Aas, Turid; Børresen, A-L et al. (1997). Angiogenesis does not predict clinical response to doxorubicin monotherapy in patients with locally advanced breast cancer. (ekstern lenke)
• Akslen, Lars A.; Mæhle, Bjørn Ove (1997). Papillary thyroid carcinoma with lipomatous stroma. (ekstern lenke)
• Straume, O; Akslen, Lars A. (1997). Prognostic importance of melanoma diameter. (ekstern lenke)
• Akslen, Lars A. (1995). Seasonal variation in melanoma progress. (ekstern lenke)
• Akslen, Lars A. (1995). Melanoma and sun exposure (letter). (ekstern lenke)
• Akslen, Lars A. (1994). Sol deg med forsiktighet !. (ekstern lenke)
• Akslen, Lars A. (1993). P53 immunostaining in melanocytic lesions. (ekstern lenke)

Forord

• Akslen, Lars A.; Watnick, Randolph S. (2017). Preface. (ekstern lenke)

Faglig foredrag

• Kraby, Maria Ryssdal; Krüger, Kristi; Opdahl, Signe et al. (2016). Microvascular proliferation in breast cancer. (ekstern lenke)
• Kraby, Maria Ryssdal; Krüger, Kristi; Opdahl, Signe et al. (2015). Microvascular proliferation in the Luminal A and Basal-like subtypes of breast cancer (AM Bofin). (ekstern lenke)

Brev til redaktøren

• Puntervoll, Hanne Eknes; Molven, Anders; Akslen, Lars A. (2014). Frequency of somatic BRAF mutations in melanocytic lesions from patients in a CDK4 melanoma family. (ekstern lenke)
• Puntervoll, Hanne Eknes; Molven, Anders; Akslen, Lars A. (2014). Frequencies of KIT and GNAQ mutations in acral melanoma. (ekstern lenke)
• Akslen, Lars A.; Jacobsen, GK; Vainio, O (2004). Angiogenesis - recent developments in molecular pathogenesis, morphological markers, and therapeutic applications. (ekstern lenke)

Sammendrag/abstract

• Tangen, Ingvild Løberg; Krakstad, Camilla; Werner, Henrica Maria Johanna et al. (2013). FOXA1 LOSS IN ENDOMETRIAL CANCER IS ASSOCIATED WITH POOR PROGNOSIS AND ER ALPHA LOSS. (ekstern lenke)
• Knutsvik, Gøril; Stefansson, Ingunn Marie; Collett, Karin et al. (2013). Proliferation markers PHH3, Ki67 and mitotic count all show significant associations with features of aggressive breast carcinomas and reduced survival. (ekstern lenke)
• Knutsvik, Gøril; Stefansson, Ingunn Marie; Collett, Karin et al. (2013). Proliferation markers PHH3, Ki67 and Mimtotic count all show significant associations with features of aggressive breast carcinomas and reduced survival. (ekstern lenke)
• Knutsvik, Gøril; Stefansson, Ingunn Marie; Collett, Karin et al. (2012). Prognostic impact of proliferation markers Ki-67, PHH3 and mitotic count in breast carcinomas. (ekstern lenke)
• Moestue, Siver Andreas; Flatabø, Silje; Huuse, Else Marie et al. (2012). Metabolic Responses to VEGF Inhibition in Patient-derived Breast Cancer Xenografts. (ekstern lenke)
• Wik, Elisabeth; Rader, Maria; Krakstad, Camilla et al. (2012). Estrogen receptor a loss in endometrial carcinoma is associated with epithelial-to-mesenchymal transition and a potential for PI3Kinase inhibition. (ekstern lenke)
• Nalwoga, Hawa; Arnes, Jarle; Wabinga, H et al. (2012). Expression of hypoxia-inducible factor-1a and associations with vascular endothelial growth factor expression, high microvessel density and features of aggressive tumors in African breast cancer. (ekstern lenke)
• Tiron, Crina Elena; Gjerdrum, Christine; Høiby, Torill et al. (2011). Axl is an essential epithelial-to-mesenchymal transition-induced regulator of breast cancer metastasis and patient survival. (ekstern lenke)
• Biermann, Martin; Johnsen, Boel; Naum, Alexandru Gratian et al. (2010). Multimodal imaging of differentiated thyroid cancer: FDG-PET-CT, I-131-SPECT-CT and ultrasound [Abstract]. (ekstern lenke)
• Stefansson, Ingunn Marie; Mannelquist, M; Salvesen, HB et al. (2010). Prognostic importance of vascular proliferation and tumor cell invasion in blood and lymphatic vessels in endometrial carcinoma. (ekstern lenke)
• Gravdal, Karsten; Halvorsen, Ole Johan; Haukaas, Svein Andreas et al. (2009). Proliferation of immature tumor vessels is a novel marker of clinical progress in prostate cancer. (ekstern lenke)
• Gravdal, Karsten; Halvorsen, Ole Johan; Haukaas, Svein Andreas et al. (2008). Vascular proliferation by Nestin/Ki-67 is a novel predictor of the clinical progress of prostate cancer. (ekstern lenke)
• Arnes, Jarle; Foulkes, William D.; Akslen, Lars A. (2008). Candidate stem cell marker ALDH1 expression and relationship with BRCA-mutations and basal-like differentiation in breast carcinoma. (ekstern lenke)
• Bachmann, Ingeborg M.; Eknes, HE; Otte, Ariel P. et al. (2007). Loss of BMI-1 expression is associated with the clinical progress of malignant melanoma. (ekstern lenke)
• Nalwoga, H; Arnes, Jarle; Wabinga, H et al. (2007). Basal-like phenotype is frequent in invasive breast carcinoma from Ugandan Africans and is strongly associated with a high expression of EGFR/c-Kit and features of aggressive tumors. (ekstern lenke)
• Gravdal, Karsten; Halvorsen, Ole Johan; Haukaas, Svein Andreas et al. (2007). Epithelial to mesenchymal transition is of strong prognostic importance in prostate cancer. (ekstern lenke)
• Rostad, Kari; Mannelqvist, Monica; Halvorsen, Ole Johan et al. (2006). ERG upregulation in relation to other transcription factors in prostate cancer. (ekstern lenke)
• Kalland, Karl-Henning; Rostad, Kari; Mannelqvist, Monica et al. (2006). Global gene expression analysis of transcription factors in prostate cancer and cell lines. (ekstern lenke)
• Kalland, Karl-Henning; Halvorsen, Ole Johan; Rostad, Kari et al. (2005). Overexpression of ERG and SIM2 transcription factors in prostate cancer. (ekstern lenke)
• Halvorsen, Ole Johan; Rostad, Kari; Øyan, Anne Margrete et al. (2005). Single-minded 2 homolog gene is overexpressed in prostate cancer. (ekstern lenke)

Vitenskapelig oversiktsartikkel/review

• Geisler, Jürgen; Bachmann, Ingeborg M.; Nyakas, Marta Sølvi et al. (2013). Malignt melanom – diagnostikk, behandling og oppfølging i Norge. (ekstern lenke)
• Engelsen, Ingeborg Bøe; Akslen, Lars A.; Salvesen, Helga Birgitte (2009). Biologic markers in endometrial cancer treatment. (ekstern lenke)
• Naumov, George N.; Folkman, Judah; Straume, Oddbjørn et al. (2008). Tumor-vascular interactions and tumor dormancy. (ekstern lenke)

Leserinnlegg

• Trovik, Jone; Wik, Elisabeth; Stefansson, Ingunn Marie et al. (2010). Stathmin is superior to AKT and phospho-AKT staining for the detection of phosphoinositide 3-kinase activation and aggressive endometrial cancer. (ekstern lenke)
• Naumov, George N.; Heymach, John; Akslen, Lars A. (2008). Dr. Folkman's legacy - a life of angiogenesis research. (ekstern lenke)
• Naumov, George N.; Watnick, Randolph S.; Almog, Nava et al. (2007). Re: A model of human tumor dormancy: An angiogenic escape from the nonangiogenic phenotype - Response. (ekstern lenke)
• Foulkes, WD; Akslen, Lars A. (2004). Germline BRCA1 Mutations and a Basal Epithelial Phenotype in Breast Cancer. (ekstern lenke)

Leder

• Akslen, Lars A.; Naumov, George N. (2008). Tumor dormancy - from basic mechanisms to clinical practice. (ekstern lenke)

Populærvitenskapelig foredrag

• Kalland, Karl-Henning; Halvorsen, Ole Johan; Rostad, Kari et al. (2005). Overexpression of ERG and SIM2 transcription factors in prostate cancer. (ekstern lenke)
• Salvesen, Helga; Akslen, Lars A.; Iversen, Ole-Erik (1997). Angiogenese - en ny og sterk prognostisk faktor ved endometriecarcinom. (ekstern lenke)
• Salvesen, Helga; Akslen, Lars A.; Iversen, Ole-Erik (1997). Recurrent endometrial and the value of routine follow up. (ekstern lenke)
• Salvesen, Helga; Akslen, Lars A.; Iversen, Ole-Erik (1997). Angiogenese - en ny og sterk prognostisk faktor ved endometriecarcinom. (ekstern lenke)

Populærvitenskapelig artikkel

• Salvesen, Helga; Iversen, Ole-Erik; Akslen, Lars A. (1998). Prognostisk betydning av tumorbiologiske markører ved livmorkreft. (ekstern lenke)
• Iversen, Ole-Erik; Salvesen, Helga; Akslen, Lars A. (1998). Prognostisk betydning av tumorbiologiske markører. (ekstern lenke)

Rapport

• Haugen, Dagny R. Faksvåg; Akslen, Lars A.; Lillehaug, Johan et al. (1993). Expression of c-erbB-2, TGF-_a, EGF receptor and c-myc in thyroid tumors. An immunohistochemical study using frozen tissue. (ekstern lenke)

Se en full oversikt over publikasjoner i Cristin